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ABSTRACT  
 
FACTORS THAT INFLUENCE BREAST CANCER DIAGNOSES IN VIRGINIA WOMEN 
40-64 YEARS OLD WHO UTLIZED THE EVERY WOMAN’S LIFE PROGRAM 1998-2012 
 
 
By Melanie Croft Dempsey, Ph.D. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015 
 
Major Director: Joann T. Richardson, Ph.D. 
Associate Professor, Health Education and Promotion 
Department of Kinesiology and Health Sciences 
 
 This dissertation examines sociodemographic determinants and preventive health 
behaviors among women 40-64 years of age who participated in the Virginia Department of 
Health’s Every Woman’s Life breast cancer screening program. Utilizing secondary data, this 
research sought to explore patterns of breast cancer incidence, mammography screening 
utilization and sources of health information among low-income women. 
 The Virginia Department of Health provided a large sample size (N=34,942) on which to 
perform binary logistic regression analyses. Sociodemographic determinants and preventive 
health behaviors were analyzed as potential influencing factors in the diagnosis of breast cancer, 
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the stage at the time of diagnosis and source of health information. Additionally, frequencies 
across all variables were explored and compared to state and national statistics, where 
appropriate. 
 In this study, cancer and preventive health disparities reported in the literature persist 
within this sample of low income women. The binary regression analyses demonstrated that 
there are marginally worse outcomes for each level of decreasing income. Those with the most 
“wealth” were less likely to be diagnosed with invasive breast cancer and were more likely to 
obtain health information from a health provider. Additionally, it was determined that those 
without a prior mammogram were more likely to be diagnosed with breast cancer and the cancer 
was more likely to be invasive.  
The aims of the Every Woman’s Life program align with Affordable Care Act (2010) to 
strengthen health care and eliminate cancer disparities. Highlighting program characteristics and 
presenting these analyses allows policymakers, program officials and practitioners an 
opportunity to tailor health promotion activities while considering all tiers of influence.  
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CHAPTER 1 
INTRODUCTION 
 
According to the American Cancer Society [ACS] (2015), breast cancer is the most 
commonly diagnosed cancer in American women, excluding cancers of the skin. Breast cancer is 
the second leading cause of cancer deaths in the United States (US) among women, second only 
to lung cancer. For American women, there is an estimated one in eight (12%) lifetime risk of 
developing invasive breast cancer during their lifetime (ACS, 2015). This translates into more 
than 232,000 new cases of breast cancer in the US annually with an estimated 6,170 diagnosed 
among Virginia women.  
While white women have the highest incidence rates of breast cancer, several disparities 
occur in comparison to other populations of US women. For example, among Hispanic women 
breast cancer is not only the most commonly diagnosed cancer, but it is the leading cause of 
cancer death in this ethnic group (ACS, 2015). Furthermore, African American women have the 
highest mortality rates from breast cancer and are 40% more likely to die from their disease than 
their white counterparts (Centers for Disease Control and Prevention [CDC], 2010). These 
disparities in survival are partially attributed to structural and personal barriers in cancer 
screening, such as access to mammography for the detection and diagnosis of breast cancer. The 
CDC cites variations in screening, follow-up and treatment patterns between white and African 
American women accounting for the differences in breast cancer death rates (CDC, 2009). The 
Institute of Medicine’s (IOM) landmark publication, Unequal Treatment: Confronting Racial 
and Ethnic Dispartities in Healthcare (2003), cites compelling evidence of racial and ethnic 
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disparities in health outcomes, including breast cancer (Smedley, Stith & Nelson, 2003). Health 
disparity is a term used primarily in the US and may be used interchangeably with the more 
universal term “health inequity” (Braveman, 2006). 
The Agency for Healthcare Research and Quality’s (AHRQ) 2009 National Healthcare 
Disparities Report central findings are that health disparities are common, insurance status is an 
important factor, many disparities are not decreasing, and cancer disparities warrant special 
attention (AHRQ, 2009). Consistent throughout the literature is the concept that access to cancer 
screening services is essential in reducing cancer health disparities.  
In response to the breast cancer epidemic and evidence of disparities in access to care, 
appropriate treatment and survival, the federal government passed Public Law 101-354, the 
Breast and Cervical Cancer Mortality Prevention Act of 1990 (CDC, 2013). This law established 
the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which is 
executed and administered by the CDC with the purpose of providing screening examinations for 
underserved women. Over the years, the quality of the program has been evaluated through 
independent analysis and research. Benard, Saraiya, Soman, Roland, Yabroff & Miller (2011) 
concluded that the beliefs and screening practices among participating physicians were similar to 
non-program providers suggesting adherence to one standard of care. Additionally, women 
screened by the program were found to receive treatment within the prescribed 60-day from 
diagnosis benchmark (Richardson, Royalty, Howe, Helsel, Kammerer & Benard, 2010). 
Researchers at the Research Triangle Institute International analyzed data that suggest the 
NBCCEDP breast cancer screening program reduced mortality among participants (Hoerger, 
Ekwueme, Miller, Uzanangelov, Hall, Segel et al., 2010).  The NBCCEDP operates in all fifty 
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states, with Virginia’s program executed through the Virginia Department of Health’s “Every 
Woman’s Life” (EWL) program.  
Paralleling the NBCCEDP, Healthy People 2020, a comprehensive framework developed 
by multiple federal agencies, stakeholders and advisory committee, also emphasizes breast 
cancer as part of its overall focus. Three main goals of Healthy People 2020 are to 1) achieve 
health equity, 2) eliminate health disparities and 3) improve the health of all groups. The Healthy 
People 2020 Objective C-17 established a goal to increase the proportion of women who receive 
a breast cancer screening by 10%, thereby, acknowledging the importance of mammography in 
the early detection of breast cancer (U.S. Department of Health and Human Services [HHS], 
2013). 
More recently, the Patient Protection and Affordable Care Act (ACA) was signed into 
law in March, 2010 (Patient Protection and Affordable Care Act, 2010). Title IV of the law 
addresses prevention of chronic disease and improvement of public health which includes a 
national prevention and health promotion strategy.  It is expected that many preventive care 
services, including mammography, will be 100% covered under this new law (IOM, 2011). 
Unless otherwise specified, a mammogram in this text will represent a screening mammogram, 
which is a series of –rays to visualize breast tissue used to detect and diagnose breast cancer. 
This is in contrast to a “diagnostic” mammogram, a term reserved for special views obtained 
after a lump or another sign of disease is found. 
Although two of the leading authorities on cancer screening, diagnosis and treatment may 
differ on issues such as the age for initial, baseline mammography screening, both agree on the 
imperative for screening to improve morbidity and mortality outcomes. The American Cancer 
Society (ACS) revised breast cancer screening guidelines in 2015 to include yearly 
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mammograms beginning at age 45. ACS is commonly recognized as a leading authority on 
cancer care for both health professionals as well as the lay population (ACS, 2015). The United 
States Preventive Services Task Force (USPSTF), another leading authority in disease prevention 
and evidence-based medicine, recommends biennial screening for women 50 to 74 years of age. 
The USPSTF is comprised of a panel of independent experts that review evidence-based findings 
and make recommendations on preventive health care services for primary care physicians and 
health systems through AHRQ. Martin and Wingfield (2012) called for a change in the USPSTF 
2009 guidelines to account for underserved populations, such as African American women, with 
low screening rates, advanced tumor stage at the time of diagnosis and higher mortality from 
breast cancer. These inconsistencies in screening recommendations may confuse the public and 
may serve as a deterrent to screening. In September 2013, published findings indicated the 
highest breast cancer mortality occurs among those not regularly screened (Webb, Cady, 
Michaelson, Bush, Calvillo, Kopans, et al., 2013). The authors recommend regular annual, rather 
than biennial, breast cancer screening beginning before the age of 50. 
Virginia’s Every Woman’s Life (EWL) program uses federal funds allocated by the CDC 
as part of the NBCCEDP to provide free mammograms and diagnostic services to low income 
female residents of Virginia ages 40-64 (Virginia Department of Health [VDH], 2013). Program 
eligibility criteria require that participants have limited or no insurance with an income at or 
below two times the established Federal Poverty Level (FPL). Though approximately 75,000 
Virginia women are eligible based on census data, funding allows approximately 7,500 (10%) of 
those eligible to receive the benefits of the program (EWL Program Fact Sheet, 2014). The EWL 
program adheres to the USPSTF 2002 screening guidelines, which are closely aligned with 
previous American Cancer Society (ACS) guidelines which recommended annual screening 
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mammograms beginning at age 40. The EWL program is a collaborative effort with 32 
enrollment sites across the Commonwealth of Virginia utilizing more than 250 clinical service -
providers. 
Rationale for the Study 
Despite efforts to eliminate health disparities, they persist chiefly among low-income 
ethnic and racial minorities (Smedley et al., 2003). This investigation explores sociodemographic 
factors that may be associated with breast cancer diagnoses in Virginia women 40-64 years of 
age who utilize the Every Woman’s Life program. Sociodemographic variables (age, race, 
education, income, insurance status, language) are widely reported in health promotion and 
public health literature. Given that one of the eligibility requirements to receive free 
mammograms through the EWL program includes an income at or below 200% FPL, this 
provides a unique opportunity to analyze data with socioeconomic status (SES) held to a 
prescribed threshold, all of which would be classified as “low income.” This research explores 
breast cancer diagnosis, stage at the time of diagnosis, and preventive health behaviors within 
this subset of Virginia women. Findings may identify trends and opportunities to recruit from 
priority populations who are currently underserved.  
The United States has an increasingly diverse population with recent census data 
projecting that by 2050, there will be no clear racial or ethnic majority. This change in the 
sociocultural composition of the US has wide-ranging implications, to include health and health 
care. Virginia has a very diverse population with one in ten residents foreign born, 40% from 
Asia and 36% from Latin America (Cardenas, Ajinkya & Leger, 2011).To illustrate, Virginia has 
25 counties in “Appalachia,” a designated area with regions characterized by depressed 
economics, high unemployment, poor health and educational disparities while northern Virginia, 
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for instance, enjoys considerable financial affluence and high educational attainment 
(Appalachian Regional Commission, 2013). According to the US Census (2014), Virginia’s 
racial demographics closely mirrors population demographics of the entire US with 70.5% 
reporting  their race as White (US, 77.4%), 19.7%  Black or African American (US, 13.2%), 
0.5% American Indian and Alaskan Native (US, 1.2%), 6.3% Asian (US, 5.4%) and 0.1% Native 
Hawaiian and Other Pacific Islander (US, 0.2%). Additionally, 14.9% of Virginian’s surveyed 
report a language other than English spoken at home while 20.7% was reported across the US 
(US Census, 2014). 
Population-based surveillance data are used extensively in cancer-related literature. 
Census, vital statistics and national health surveillance tools are used to assess health attitudes, 
behaviors and knowledge. While these tools provide valuable data, each have limitations and do 
not provide detailed information on a state or regional level. For example, the Behavioral Risk 
Factor Surveillance System (BRFSS), established in 1984 by the CDC, is a state-based random-
digit-dialed telephone survey, expanded in 2011 to include cell phone numbers (CDC, BRFSS 
History, 2013).  Conducting over 400,000 interviews annually, the BRFSS is the largest 
telephone survey providing information about health risk behaviors, chronic health conditions 
and use of prevention services among US residents. Often cited in breast cancer screening 
literature are mammographic screening rates derived from BRFSS survey data. The 2010 BRFSS 
found 77.7% of Virginia women >40 years of age self-reported having a mammogram in the past 
two years as compared to 75.4%, the national average. 
Statistics, available on both government and non-governmental organization websites 
such as the American Cancer Society’s website, www.cancer.org, are primarily reported from the 
Surveillance, Epidemiology and End Results program (SEER) data.  SEER is the only national 
 
 
10 
 
program that provides stage of disease at the time of diagnosis along with survival data.  It is a 
program in the division of the Cancer Control and Population Sciences at the National Cancer 
Institute (National Cancer Institute [NCI], 2015). Additionally, the National Cancer Data Base 
(NCDB) is a joint effort of ACS and the Commission on Cancer. Begun in 1989, the NCDB is an 
outcomes database which compiles cancer registry data and captures more than 75% of all new 
cancer diagnoses in US. These data are tracked and analyzed, revealing important trends in 
cancer incidence and treatment. In addition, the EWL Cancer Statistics and Tracking (CaST) 
database is routinely synchronized with the Virginia Cancer Registry. Part of the information 
exchanged via an electronic interface includes American Joint Commission on Cancer (AJCC) 
staging information, which is considered essential information to cancer care professionals. In 
this study, AJCC staging is used to operationalize “early” and “not early” breast cancers. 
Plescia & White (2013) report gaps in screening among the low-income women, 
uninsured and women without a usual source of care. These same authors found nonfinancial 
factors that may influence a woman’s ability to assess screening services which include 
language, geography, cultural differences, provider biases, lack of social support and lack of 
knowledge. There is a large volume of literature dedicated to identifying barriers to preventive 
health behaviors, particularly cancer screenings. Though it is important to identify barriers and 
recognize gaps in mammographic screening, women utilizing EWL services are assumed to have 
overcome barriers in that they successfully secured a mammogram. 
 
Statement of Purpose 
With the primary aim of this study being to identify factors are associated with a breast 
cancer diagnosis among the low-income population utilizing EWL services in Virginia, it is 
 
 
11 
 
necessary to evaluate and report data beyond the current scope of EWL reporting. The CDC 
requires specific quality measures and statistics from states receiving NBCCEDP funding. 
However, reports generated by the CDC are limited to women served, women screened, and 
women receiving mammography, the percentage of abnormal mammograms, and total number of 
cancers diagnosed. Therefore, the aggregated data offers little insight into the differences among 
and within groups utilizing EWL mammography services. Beyond addressing the statistical 
analyses, this research study will consider both practice and policy implications for the EWL 
program based on the findings. 
Sociodemographic (age, race, education, language, geographic locale and income) 
differences between those diagnosed and those not diagnosed with breast cancer, including stage 
at the time of diagnosis, were analyzed. Preventive health behaviors such as having a prior 
mammogram and smoking cessation intent was used to further examine stage at the time of 
diagnosis in this sample of women. Additionally, sources of information to access the program 
were explored by the same sociodemographic variables as previously delineated. The EWL 
mammography screening program provides detailed participant demographic and cancer data 
which permit these analyses. Research using this type of individual level data is limited in the 
literature. More commonly in health promotion and public health research, large scale population 
surveys serve as the source of data. 
To date, there is no published literature exploring data from Virginia’s Every Woman’s 
Life program outside of volume statistics reported on the CDC and Virginia Department of 
Health (VDH) websites. To provide a frame of reference for this study, an overview of breast 
cancer literature including risks, screening, cancer incidence and mortality, pertinent legislation 
as well an introduction to the socioecological model follows. 
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Overview of the literature 
 Breast cancer is the most commonly diagnosed cancer among US women (NCI, 2014). 
As such, it has been the topic of much research investigating the disease itself, incidence and 
mortality rates, risk factors, and barriers to both screening and treatment. It bears repeating that 
the American Cancer Society estimates one in eight women in the US to develop breast cancer in 
their lifetime (ACS, 2015). Cancer statistics are compiled and published through the NCI’s 
Surveillance, Epidemiology and End Results Program (SEER) recognized as a premier, trusted 
source. Risk factors that are modifiable, such as diet, smoking status and exercise, are of 
particular interest in preventive health research. Preventive health behaviors and their influence 
on disease incidence and severity of disease are abundant in the literature. Mammography, 
considered a preventive health behavior, is reported to reduce breast cancer mortality by 10-25% 
(Nelson,Tyne, Naik, Bougatsos, Chan & Humphrey, 2009). Early detection and appropriate 
treatment improves health outcomes, most often measured in decreased cancer mortality rates. 
Barriers to mammography include insurance, lack of physician recommendation, facility 
capacity and geographic isolation to name a few. In a study by Sabatino, Coates, Uhler, Breen, 
Tangka & Shaw (2008) the greatest difference in mammography use was among those with and 
without insurance.  
Breast cancer incidence and mortality varies disproportionately across racial and ethnic 
groups-these disparities are explored in the literature. The compelling evidence of breast cancer 
screening and mortality disparities reported in the literature, along with a favorable political 
climate, led to the enactment of the National Breast and Cervical Cancer Mortality Prevention 
Act in 1990. While this program provided needed screening services to low-income women, 
there were no provisions for treatment of women diagnosed with cancer by utilizing these 
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screening and diagnostic services. To alleviate this issue, the Breast and Cervical Cancer 
Prevention and Treatment Act of 2000 (BCCPTA) provided a mechanism to fund treatment for 
women diagnosed through the NBCCEDP through Medicaid expansion (Breast and Cervical 
Cancer Prevention and Treatment Act of 2000, 2000). The most recent legislation to impact 
breast cancer screening is the Patient Protection and Affordable Care Act (ACA) signed into law 
March 2010 by President Barack Obama (Patient Protection and Affordable Care Act, 2010). 
Though the law is not expected to be fully implemented until 2015, preventive care is a major 
provision of the law. As such, mammograms are expected to be covered across all insurance 
plans with the elimination of cost-sharing, where the consumer does not incur any out-of-pocket 
expenses for the service. Through the ACA, a National Prevention Council was established to 
guide and coordinate efforts across agencies to move the US toward a “prevention-oriented” 
society (National Prevention Council, 2010). 
  
Theoretical Framework 
 With so many influences on a woman’s decision and ability to participate in preventive 
health services, such as mammography, the socioecological model (SEM) is an appropriate 
framework with which to work. First used to describe preventive health interventions by 
McLeroy, Bibeau, Steckler and Glanz in 1988, the socioecological model accounts for 
individual, interpersonal, organizational, community and public policy influences. The social 
ecological model, depicted in figure 1.0, is a systems model utilized in health promotion, health 
disparities research and cancer prevention programs (Golden and Earp, 2012). In as much as 
health and health behaviors are not determined by any single factor, this interactive model can 
help frame the EWL breast cancer screening program at every level. The levels of influence 
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identified in the social ecological model are individual, interpersonal, organizational, community 
and policy. While a more detailed and expanded presentation of the model appears in Chapter 2, 
it is important to recognize that each structural level may be simultaneously influenced by one or 
more of the other layers. A key concept of the ecological perspective is “reciprocal causation”, 
whereby individual health behaviors both impact and are impacted by their social environment 
(Rimer & Glanz, 1997). For instance, a woman contemplating her first mammogram may seek 
information from a community health fair (community level), the local health department 
(organizational level) and a trusted friend or relative (interpersonal) before taking action to 
obtain the mammogram. Once empowered to obtain the mammogram, perhaps the woman 
encounters structural barriers such as access to a facility with suitable hours of operation to 
accommodate her work schedule. Through inquiry and petition the woman (individual level) is 
able to influence local health department (organizational level) to provide mobile mammography 
in her community thus inspiring her peers (interpersonal level) to obtain screening mammograms 
as well. This illustrates the bi-directional influences that impact the success or failure of a health 
promotion program or cancer screening program. The EWL program was not developed in 
isolation nor can it be successful without attention from all stakeholders at all levels, from 
consumers to lawmakers.  
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Figure 1.0 Socioecological model of the Every Woman’s Life program 
 
In order for eligible individuals to take advantage of free breast cancer screenings, there 
must be programmatic support at the organizational, community and public policy levels. Public 
policy, at the outermost level of influence, provides the framework and funding for the EWL 
program. Other policies, less directly involved but important to program success, would be 
federal, state and local policies which impact public transportation, impacting access to medical 
services. Also at the policy level, changes in screening and clinical guidelines determine an 
individual’s eligibility for and access to the breast cancer screening program.  
The next structural level of the socioecological model (community) provides breast 
cancer education and awareness, often serving as the impetus for action. Community health 
programs, media campaigns or employer/worksite initiatives are considered part of the 
community level of the influence. Organizational levels of influence would include the EWL 
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program itself and its’ community coalition partners and clinical service providers (hospitals, 
clinics, and health departments).  
Individuals operate within their own interpersonal networks and may use this extended 
family as “sounding boards” for health decisions. Interpersonal levels of influence may include: 
1) providers, 2) family, 3) community health workers, 4) friends and 5) patient navigators. 
Finally, the individual level of influence hinges on the concept of self-efficacy (Bandura, 1977) 
which plays a role in one’s movement toward healthy choices. Biological and personal history 
factors such as race, age, education, income, primary language and geographic location influence 
an individual’s likelihood of modifying or adopting a health behavior (Rimer & Glanz, 2005). 
Individuals must have adequate knowledge, favorable attitudes and beliefs that encourage 
preventive health behaviors, such as cancer screening and smoking cessation before definitive 
action is expected (Werle, 2011).  
Maintenance and growth of programs, like the EWL program, have continued reliance on 
public policy, support from the community, organizational backing, acceptance and promotion 
among the medical and lay communities and finally, the courage of individuals to overcome 
personal barriers to screening. 
 
Research Questions 
This research provides a basis for understanding and evaluating various influences on breast 
cancer diagnoses among participants in Virginia’s Every Woman’s Life program. Data elements 
secured include demographics (age, race, language, county of residence), economic measures 
(levels of income and education), preventive health behaviors (prior mammogram, intent to quit 
smoking) and source of referral to the EWL program, along with cancer diagnostic and staging 
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information. The socioecological perspective recognizes these individuals, as part of a social 
environment and the EWL network, thereby having multiple levels of influence which impact 
health outcomes, such as breast cancer. Within this framework and these data parameters, the 
overarching question is: What factors can be identified that may influence breast cancer 
diagnoses among low income women 40-64 years old? The following research questions are 
designed to answer the overarching question. 
Research question one (RQ1).  What is the association between socio-demographic 
determinants (race, age, income, education, language and geographic location) and prior 
mammography and cancer diagnosis among women 40-64 years of age utilizing EWL 
services? 
Research question two (RQ2). What is the association between socio-demographic 
determinants (race, age, income, education, language and geographic location) and prior 
mammography and cancer stage at the time of diagnosis among women 40-64 years of age 
utilizing EWL services? 
Research question three (RQ3). What is the association between socio-demographic 
determinants (race, age, income, education, language and geographic location) and source of 
information among women 40-64 years of age utilizing EWL services? 
 
Design and Methods  
 This non-experimental study analyzed existing data from the Every Woman’s Life 
database (CaST), comprised of all breast cancer screening participants in calendar years 1998 
through 2012. The selected timeframe begins with the first full calendar year of the EWL 
program and concludes with the last year data synchronization with the Virginia Cancer Registry 
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was initiated, intended to provide AJCC staging information for breast cancers diagnosed. These 
data were made available through the VDH, following Institutional Review Board (IRB) 
approval by both Virginia Commonwealth University (Appendix A) and the VDH (Appendix B), 
which required a data use agreement (Appendix C). This data set contains 34,942 participants 
and of these, 1143 had a breast cancer diagnosis. The sample was limited to women 40-64 years 
of age.  
Detailed descriptive and inferential statistics are presented in Chapter 3. Logistic 
regression models were used to answer each of the research questions. Sociodemographic factors 
(age, race, income, language, geographic locale and education) were used as independent 
variables with dichotomous categorical dependent variables breast cancer diagnosis in RQ1 and 
breast cancer stage in RQ2. Trusted source of health information was the dependent variable in 
RQ3 with a calculated independent variable consisting of two preventive health behaviors, prior 
mammogram and smoking cessation intent. 
 
Organization of Remaining Chapters 
The remaining chapters present the existing literature on the subject, the methodology, 
the results and the discussion and conclusions. Chapter 2 presents an extensive review of 
previous research on the topic and an explanation of the appropriateness of the theoretical 
framework chosen to examine the topic. Chapter 3 elaborates on the study sample and outlines 
the research design and statistical methods used to conduct the analyses. The empirical results 
are detailed in Chapter 4. Lastly, Chapter 5 summarizes and discusses the study results, draws 
conclusions and offers recommendations for future research. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
The underutilization of screening mammography for early breast cancer detection and the 
reduction of disparities in breast cancer morbidity and mortality in underserved women has been 
a focus of much research. In order to examine the extant literature related to the research 
questions in this study, an extensive review of the literature was conducted. This review 
describes several areas of prior research relevant to this study, including breast cancer and its’ 
associated risk factors, mammographic screening access, guidelines and utilization, breast cancer 
disparities, preventive health behaviors and the impact of legislation and policy. 
The literature review covers the period 1990-2015, a period marked by several significant 
breast cancer control milestones. Those milestones include key pieces of legislation, landmark 
publications, national healthcare initiatives and prevention programs as depicted in Appendix D. 
The literature review is organized and presented within eight interrelated topics following the 
“Method for the Review of the Literature:” 
Breast Cancer Trends 
Breast Cancer Risk Factors 
Mammographic Screening and Guidelines 
Mammographic Capacity and Access 
 Impact of Barriers on Mammographic Screening Rates 
Breast Cancer Disparities 
 The Impact of National Legislation and Policy 
National and State Breast Cancer Screening Programs 
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Preventive Health Behaviors 
Trusted sources of health information 
Theoretical Framework 
Method for the Review of the Literature 
Search criteria.  The search parameters included studies published in peer-reviewed 
journals from 1990 to present. The year 1990 was used as a lower limit to coincide with the 
enactment of the Breast and Cervical Cancer Prevention and Mortality Act which spawned the 
NBCCEDP. Keywords, used in various combinations included:  breast cancer, cancer disparities, 
mammography, cancer screening, barriers, NBCCEDP. An initial list of studies was created 
through searches of the following databases:  Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), MEDLINE/PubMed, Social Science Abstracts, Women’s Studies 
International, Education Research Complete, Academic Search Complete and Health and 
Psychosocial Instruments. Publications produced by the National Academies Press, Institutes of 
Medicine (IOM) and other government agencies such as AHRQ were hand searched for 
important works. Additionally, references of primary sources were also hand searched. Internet 
websites of premier oncology and government agency websites were explored to obtain the most 
up-to-date information. Sources for research methods and statistical analysis, including textbooks 
and websites, were utilized to aid the researcher in conducting this review. 
 Selection criteria. All articles from the initial search were hand searched for titles and 
abstracts pertinent to the topic.  Upon review, 150 were deemed relevant while 25 were removed 
from review.  In total, 98 journal articles, 10 textbooks and 15 agency reports, manuals and 
factsheets were utilized in the final analysis, along with numerous statistical references. 
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Breast Cancer Trends  
 With the exception of skin cancer, breast cancer is the most commonly diagnosed cancer 
among women in the United States (National Cancer Institute [NCI], 2015). Breast cancer is 
second only to lung cancer in cancer deaths among US women (NCI, 2015). However, among 
Latino women, breast cancer is the leading cause of cancer mortality (American Cancer Society 
[ACS], 2015). The ACS reports a 12% (one in eight) lifetime risk of developing breast cancer for 
all women in the United States (ACS, 2015).  Further, 2015 ACS statistics estimate 231,840 
women will be diagnosed with breast cancer  with 40,290 estimated deaths (ACS, 2015). While 
breast cancer does occur in men, it is 100 times more likely in women (NCI, 2015). As such, this 
discussion will be limited to breast cancer as it impacts women in the United States. The NCI 
and ACS are often cited as the source for cancer statistics, the premier primary source for United 
States (US) cancer incidence and survival statistics is the Surveillance, Epidemiology and End 
Results Program (SEER) of the NCI. 
 Breast cancer, as in all other types of cancer, is diagnosed at various stages.  It is 
generally accepted that better outcomes result when cancers are diagnosed early.  Simply stated, 
less advanced cancer is predictive of a better prognosis or disease-free interval (Soerjomatoram, 
Louwman, Ribot, Roukema, Willem & Coebergh, 2008).  Figure 2.1 reflects the 2005-2011 five 
year relative survival data. Cancer stage at the time of diagnosis is also significant in determining 
the appropriate individual treatment regimen (NCI, 2015). 
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Figure 2.1 Breast Cancer  2005-2011, All Races, Females 5-Year Relative Survival by SEER Summary Stage 
Source:  SEER, 2015 
 
 
Breast Cancer Risk Factors  
A risk factor increases the probability of developing a disease. Risk factors for breast 
cancer can be divided into those which can be altered (modifiable) and those that cannot be 
altered (non-modifiable) by the individual. Increasing age is the strongest risk factor for breast 
cancer (NCI, 2015). Most recent data estimates a 1 in 68 (1.47%) risk of a woman developing 
breast cancer during her fourth decade of life, increasing to 1 in 42 (2.38%) when a woman 
reaches 50 years of age. Additional increases in risk are expected in the sixth and seventh 
decades of life (3.56%, 3.82%, respectively). Other risk factors which are non-modifiable 
include race, genetic predisposition, family or personal history of breast cancer, breast tissue 
density, early menarche, and previous radiation therapy. Modifiable risk factors may include 
obesity, alcohol use, and low levels of physical activity (ACS, 2015).  
 The incidence of new cases of breast cancer has been found to vary by race as depicted in 
Table 2.1 based on the most recent data (SEER, 2015). In the US, white women experience the 
 
 
23 
 
highest breast cancer incidence with 127.9 new breast cancer cases per 100,000, while American 
Indian/Alaska Native (AI/AN) women have the lowest reported incidence at 82 new breast 
cancer cases per 100,000 per year. However, breast cancer screening and mortality (death) rates 
do not follow this same pattern. In other words, though white women have the highest incidence 
of breast cancer diagnoses they do not have the highest breast cancer mortality rates. At 30.2 
breast cancer deaths per 100,000, African American women experience disproportionate 
mortality compared to white women (21.3 per 100,000) and all other racial and ethnic groups 
(SEER Stat Fact Sheet: Breast Cancer, 2015). These disparities in screening rates and breast 
cancer mortality across racial and ethnic groups are the focus of much cancer research.  
Table 2.1 
  Breast cancer incidence and mortality by race/ethnicity 
 
New cases per 100,000 Number of Deaths per 100,000 
All races 124.8 21.9 
White 127.9 21.3 
Black 124.4 30.2 
Asian /              
Pacific Islander 96.3 11.4 
American Indian 
/ Alaskan Native 82.0 15.0 
Hispanic 92.1 14.5 
Non-Hispanic 130.1 22.6 
   U.S. 2008-2012, Age-Adjusted 
 Source:  2015 SEER Stat Fact Sheet 
  
Mammographic Screening and Guidelines 
Screening mammography is a series of x-rays of both breasts used to detect and diagnose 
cancer in women who exhibit no signs or symptoms (NCI, 2014). It is desirable to detect breast 
cancer at its’ earliest stages, before the disease spreads to other tissues. With early detection 
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healthcare providers may initiate treatment sooner in the disease process, when treatment is most 
effective. 
 It has been widely accepted that benefits of mammography outweigh the risks associated 
with the low dose of radiation associated with its’ delivery (NCI, 2014). In the literature, 
mammography accounts for 10-25% reduction in breast cancer mortality (Nelson et al., 2009). 
An IOM and National Research Council committee concluded that mammography is the best 
strategy to save women’s lives (Joy, Penhoet & Petitii, 2005). Most recently, however, the 
benefits of mammography have been challenged in the literature and in the mainstream media. 
One Canadian randomized trial with 25 year follow-up data concluded annual mammography 
does not reduce breast cancer mortality differentially than routine physical examinations when 
adjuvant therapy for breast cancer is available (Miller, Wall, Baines, Sun, To & Narod, 2014). 
Pace and Keating (2014) reviewed decades of breast cancer screening literature and concluded 
that while mammography is associated with a reduction in breast cancer mortality, there is a high 
risk (61%) for a false-positive result for 40-50 year old women receiving annual mammograms. 
Ultimately, Pace and Keating (2014) recommended individualized screening decisions based on 
patients’ individual risk factors and personal preferences. While individual screening guidelines 
and shared decision making are ideal, as acknowledged by Elmore and Kramer (2014), high-risk 
populations continue to need frequent breast cancer screenings.  
 The USPSTF breast cancer screening guidelines, revised in 2009, are no longer congruent 
with the ACS recommendations. According to the USPSTF, women aged 50 to 74 years of age 
should have screening mammography every two years.  In contrast, the ACS recommends yearly 
mammograms beginning at age 45, with no endpoint (Oeffinger, 2015). This inconsistency may 
add confusion or suspicion among women, particularly among underserved or marginalized 
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populations. This, in turn, may trigger delays in obtaining appropriate screening mammograms 
or preclude them from screening altogether. Martin and Wingfield (2012) highlight the potential 
negative impact on the African American community by the revised USPSTF screening 
guidelines which recommend biennial screening for women aged 50-74. Interestingly, the impact 
of the very recent ACS revisions to their guidelines remain to be studied. 
 Healthy People 2020, a nation-wide initiative focused on improving the health of 
Americans, established an objective (C-17) to increase the proportion of women who receive a 
screening mammogram according to the most recent USPSTF guidelines to a target level of 
81.1% since breast cancer continues to be a prominent health issue in the United States (USHHS, 
2013). These guidelines have come under scrutiny following the publication of a recent Cancer 
journal article citing most breast cancer deaths occur in women not regularly screened (Webb et 
al., 2013). If confusion exists among health care professionals as to the appropriate age for and 
frequency of breast cancer screening, this only adds to the list of barriers to screening for women 
in the U.S. 
Mammographic Capacity and Access 
 Access to mammography is consistently reported in the literature as a barrier to 
screening.  More specifically, access may be complicated by insurance status, transportation, or 
simply the lack of a facility nearby. The United States Government Accountability Office (GAO) 
reported the mammography capacity across the US is adequate, but noted limited access in 
certain locations (GAO, 2006). The number of mammography facilities decreased from 2001 to 
2004. The loss or absence of mammographic units in some areas result in longer wait times or an 
increase in distance traveled to obtain services, negatively impacting those residents.  These 
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access problems may particularly impede uninsured and low-income women who already have 
lower than average utilization of mammographic services (GAO, 2006). 
 In 2012, researchers examined the relationship between mammography capacity and 
population characteristics at the county level (Peipins, Miller, Richards, Bobo, Liu, White et al., 
2012).  Twenty-seven percent (n=870) of counties in the United States have no mammography 
facilities. These counties typically have low population density, low numbers of primary care 
physicians and low percentage of insured residents. Elkin, Atoria, Leoce, Bach & Schrag (2013) 
assessed changes from 2000 to 2010 in the availability of screening mammography in the US. 
Findings reported by Elkin et al. (2013) reinforced breast cancer disparities identified in counties 
with no or limited mammography capacity. Cross sectional analysis revealed counties with more 
uninsured residents, less educated residents, greater population density and a higher percentage 
of managed care had lower mammography capacity.  
Impact of Barriers on Mammographic Screening Rates 
 Using National Health Interview Survey data, Sabatino et al. (2008) reported the greatest 
disparity in mammography use among the uninsured when compared to women with insurance. 
Consistent in the literature, income was reported to be a barrier to screening with low 
mammography use among low-income women and the highest use among women with high 
incomes. Sabatino et al. (2008) found no disparity in mammography use among African 
Americans compared to white women, but Asian women had the lowest self-reported 
mammography use among all racial groups represented in the survey. The authors acknowledged 
a small sample size may have impacted the reliability of some estimates in this group of women. 
A CDC report using BRFSS data also found the lowest screening rates among women with 
household incomes less than $15,000 and without insurance. In contrast to Sabatino et al. (2008), 
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the CDC report indicated the lowest mammography screening rates among American 
Indian/Alaska Natives.  
In a survey study of women (n=1,242) in central Texas, researchers reported the 
relationship of screening rates with demographic, health status and health care access factors 
(Smith, Hochhalter, Ahn, Wernicke & Ory, 2011). No racial or ethnic minority disparity in 
screening mammography was found. Ninety-three percent of respondents reported having a 
mammogram during their lifetime with 76.2% having a mammogram in the past two years. 
Those without a routine mammogram in past two years reported a lapse in insurance or live in a 
health care provider shortage area, both of which represent a problem with access to health care. 
In a cross-sectional study (n=178) of low income African American women, Young, 
Schwartz and Booza (2011) conducted interviews in a high cancer mortality area of Detroit, 
Michigan. The authors defined structural barriers as the lack of insurance, provider and/or 
facility. Clinical barriers included communication and education.  The third barrier, personal, 
analyzed in this study included knowledge and lack of trust.  Most commonly identified 
structural barriers among participants included long wait times for mammography services 
(29%), mammography not covered by insurance (18%), no facility in area (18%), no 
transportation (16%) and cost (15%).  In addition, poor communication and education were 
recognized as clinical barriers to mammography use. Incorrect knowledge of cancer risk factors, 
effectiveness of screening mammography and fear of surgery were among the highest ranked 
personal barriers. In their analysis, statistically significant structural barriers were the lack of 
health insurance and lack of a regular health care provider or facility. Personal and structural 
barriers may not be impacted by healthcare providers, but clinical barriers, such as education and 
recommendation for mammography, are within their scope or range of influence.  
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Statistics continue to indicate eligible women are not screened at recommended levels or 
frequencies (Mortality and Morbidity Weekly Report, 2010). Using BRFSS data, the CDC 
reported a 81.1% overall screening rate among 50-74 year old women in the United States.  
According to that report, American Indian/Alaska Native women had the lowest screening rate at 
70.4%. Socio-demographic factors appear to impact screening rates. Uninsured women were 
screened at 56.3% as compared to 83.8% of insured women.  Low income, defined as less than 
$15,000 annual income, negatively impacted breast cancer screening rates among US women 
with only 69.4% reporting mammography screening in the past two years. Level of education 
was correlated with screening rates with the lowest screening rate among those not finishing high 
school. Similarly, Young, Schwartz and Booza (2011) reported lack of knowledge and 
subsequent fear were deterrents to low income, medically underserved African American women 
obtaining mammograms. Other ethnic and racial minority groups, such as Thai, American 
Indian/Alaska Native and African Americans studied in the literature report education, literacy, 
knowledge and fear as personal barriers to screening (Daley et al., 2012). 
In a systematic review of the literature, Schueler, Chu and Smith-Bindman (2008) 
reported lack of physician recommendation as a primary reason for not having a mammogram. 
This is consistent with other breast cancer screening literature including a survey conducted by 
Smith et al. (2011) among middle-aged and older women in central Texas. Nuno, Castle, Harris, 
Estrada, and Garcia (2011), in a cross-sectional study of 504 Arizona residents, also concluded 
clinician recommendation may improve screening rates among Hispanic women living near the 
US-Mexico border.  
Smith et al. (2011), with data obtained from a random sample of mailed surveys, found 
low screening rates among participants living in a health care provider shortage area. Through 
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evaluation of NHIS data, Sabatino et al. (2008) also recognized those without a usual source of 
care or medical home reported lower mammography use.  Principles of a patient-centered 
medical home are explored by Ferrante, Balasubramanian, Hudson and Crabtree (2010) using 
hierarchical linear modeling with survey and chart audit data from 24 primary care offices. They 
found a high correlation between preventive services and participation in a patient-centered 
medical home. Promoting cancer screening is one core element of the newly designated patient 
centered medical home (Sarfaty, Wender & Smith, 2011). 
Daley, Filippi, James, Weir, Braiuca, Kaur et al.(2012) conducted a qualitative study to 
assess needs and barriers to mammography among American Indians in Kansas. The researchers 
conducted interviews with community leaders (n=13) as well as providers (n=17). Barriers 
identified by community leaders included fear, access and embarrassment. Among providers, 
barriers identified were education and access to services. These barriers are consistent with 
difficulties across the US when promoting breast cancer screening in diverse populations. The 
primary findings included participants’ request for culturally-appropriate information/education, 
health literacy promotion and patient navigators.  
American Indians/Alaskan Natives report low screening rates while breast cancer 
incidence is on the rise and mortality is higher than their white counterparts (Daley et al., 2012). 
Screening prevalence, as depicted in Figure 2.2, varies across racial and ethnic groups. Screening 
adherence impacts the stage at which breast cancer is detected which may impact treatment and 
ultimately, survival or conversely, mortality. Disparities in breast cancer mortality exist among 
low-income, racial and ethnic groups which means survival varies by more than incidence. 
Research continues to explore factors that may explain these disparities. 
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Figure 2.2 , Mammographic screening rates by race/ethnicity 
Source:  CDC, 2010 
 
 
Breast Cancer Disparities 
 As previously discussed, breast cancer screening and survival rates do not follow the 
racial and ethnic incidence rates of breast cancer in the United States. That is, racial groups with 
the highest breast cancer incidence do not have the highest breast cancer mortality rates. Breast 
cancer disparities are widely explored in the literature.  Certain factors associated with breast 
cancer that saturate the literature that will be addressed here include: age, race, ethnicity, 
language, geographic locale, education, socioeconomic status (SES) and insurance status. Others, 
beyond the scope of this study, include disabilities, obesity, biologic indicators, travel time or 
access to mammographic facilities and cultural beliefs. An emerging body of evidence suggests 
disparities in breast cancer mortality among racial and ethnic minority groups may be greatly 
influenced by tumor biology (Krieger, 2013). 
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 A 2012 CDC report used United States Cancer Statistics data to calculate racial 
disparities in breast cancer severity (MMWR, 2012). African American women, despite lower 
incidence rates, had a 41% higher mortality rate from breast cancer.  Additionally, African 
American women were diagnosed at later stage compared to white women (45% versus 35%) 
and experienced more cancer deaths per 100 breast cancers (27 versus 18). Despite declining 
breast cancer death rates in the US since 1990, this report concludes all racial groups have not 
benefited equally. Both individual and health system level recommendations for public health 
practice are suggested. At the individual level, timely follow-up and state-of-the-art treatment are 
recommended while performance-based reimbursement, an increase in information technology 
use, and reporting protocols for quality indicators were system level recommendations. 
 Studies have suggested African American women are more likely to have late-stage 
breast cancer at diagnosis than their non-Hispanic white counterparts. In a cross-sectional study, 
researchers explored the influence of race, ethnicity and individual SES factors on breast cancer 
stage at diagnosis (Lantz, Mujahid, Schwartz, Janz, Fagerlin, Salem et al., 2006). Using SEER 
data combined with survey results (n=1,700) in a sample of White, African American and 
Hispanic women, the researchers found minority women were more likely to be diagnosed with 
later stage breast cancer than were White women. Even when controlling for age and individual 
SES factors, the odds of early detection were significantly less among African American and 
Hispanic women. Further, the researchers found that differences in stage of breast cancer at 
diagnosis remained significant even when controlled for education and income. 
 There is some disagreement in the literature as to whether these differences are 
attributable to race or socioeconomic status or some combination thereof. One such study 
(n=5,719) specifically aimed to account for the influence of race and SES on stage at the time of 
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diagnosis, treatment, and survival (Bradley, Given & Roberts, 2002).  The researchers linked 
SEER data to Medicaid enrollment files for Michigan and found race was not significantly linked 
to unfavorable breast outcomes. However, they did find low SES was associated with late-stage 
breast cancer at the time of diagnosis, type of treatment received and mortality rates.  
 Maloney, Koch, Erb, Schneider, Goffman, Elkins & Laronga (2006) explored racial 
differences in newly diagnosed breast cancer in women of equivalent socioeconomic status. 
Though the sample was small (n=52), the researchers assessed multiple factors including age at 
the time of menarche, first live birth, menopause and diagnosis, pathologic size of the tumor, 
lymph node status, body mass index (BMI), type of diagnostic biopsy or surgery, tumor 
histology and receptor status, treatment and length of follow-up. Statistically significant 
differences were found in the age at the first live birth, where African American women were 
three years younger than the Caucasian sample.  The only other significant findings included less 
use of diagnostic ultrasound and sentinel lymph node biopsy within the African American 
sample compared to the Caucasian group. The researchers acknowledged that the reasons for 
racial disparities in breast cancer mortality appear to be multi-factorial, but present poverty as 
one confounding factor in the analysis of this complex problem. 
 Sassi, Luft and Guadagnoli (2006) assessed whether mammography screening rates were 
correlated to improved breast cancer stage at diagnosis using data from five state cancer 
registries (n=379,917) and the Behavioral Risk Factor Surveillance System from 1990-1998. The 
researchers found that African American women, even with higher screening rates, had a lower 
proportion of early stage breast cancers in the sample. In other words, despite an increase in 
breast cancer mammographic screening in the 1990s which led to earlier diagnosis within each 
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racial/ethnic group, was found to have the smallest positive effect was found among African 
American women.  
  Harper, Lynch, Meersoman, Breen, Davis and Reichman (2009) evaluated trends in 
socioeconomic and racial/ethnic disparities in breast cancer incidence, stage at diagnosis, 
screening, mortality and survival among women ages 50 and over using 1987-2005 SEER and 
NHIS data. Using four SES and five racial/ethnic groups, the researchers calculated both rate 
differences and rate ratios as measures of disparity among and between the subgroups. While 
most area-socioeconomic and race-ethnic disparities declined across all outcomes, race-ethnic 
disparities for mortality (24%) and 5-year mortality (17%) increased along with area-
socioeconomic disparities in mammography use (161%). The results suggest improvement in 
these disparities over time but the researchers urge continued focus on research, treatment and 
policymaking.  
 An analysis of California Cancer Registry data from 2000-2010 explored the association 
of race/ethnicity and SES with the risk of breast cancer mortality among 179,143 diagnosed 
cases of stages 1-3 invasive breast cancer (Parise & Caggiano, 2013). Regression analysis was 
used to assess these previously reported disparities within each stage and SES group. For Stage 1 
cases, no increased risk of cancer mortality was observed for any race or ethnicity when 
compared with whites across all SES groups. For both Stage 2 and 3 cases, African American 
women in the intermediate and high SES groups had increased risk of mortality compared to 
white women. This finding, if considered in isolation, supports breast cancer disparities among 
racial minorities across socioeconomic strata. Once adjusted for age, year of diagnosis, receptor 
status and tumor grade, the authors found less disparity concluding that the role race and 
ethnicity play are less clear and continued research is necessary (Parise & Caggiano, 2013).  
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 Another California study examined SES and race/ethnicity as predictors of breast cancer 
stage at diagnosis (Flores, Davidson, Nakazono, Carreon, Mojica & Bastani, 2013). Though 
published in 2013, the study used California Cancer Registry data from 1990-2000, along with 
1990 and 2000 US Census data. Rather than Stages 1-3, breast cancer stages in this study were 
identified as in situ, local, regional and distant diagnoses. Individual (age, race/ethnicity and 
marital status) and community characteristics (education and income by zip code) were used as 
socio-demographic determinants. Overall, there was an increase of in situ diagnoses with an 
associated decrease in regional and distant cancer diagnoses. This pattern held true for white and 
Asian/Pacific Islander women while African American women had a significant decrease only in 
distant-stage diagnoses. Hispanic women showed no significant changes in any stage of 
diagnosis during the studied time period. Therefore, an increase of in situ cases diagnosed among 
low income and low education zip codes was observed, leaving Hispanic women with the least 
improvement in breast cancer stage at diagnoses. These findings are important in guiding 
screening and education programs, given California’s rapidly growing Hispanic population. 
 Rauscher, Allgood, Whitman and Conant (2012) surveyed mammography facilities 
(n=40) in the Chicago, Illinois metropolitan area to assess whether disparities in these services 
by race/ethnicity and health insurance exist. Facility characteristics, along with mammographic 
equipment and personnel were considered in this study. White women were significantly more 
likely than African American or Hispanic women to have mammograms at high quality facilities 
with digital mammography and breast imaging specialists. Similarly, women with private 
insurance were more likely than women without private insurance to have mammograms at 
academic facilities where these same favorable characteristics are observed. The results suggest 
that these disparities in obtaining high quality mammograms among African American and 
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Hispanic women and women without private insurance may contribute to breast cancer mortality 
disparities observed in these same groups. These studies represent a vast body of literature that 
have explored the impact of race and ethnicity, socioeconomic and insurance status on various 
breast cancer outcomes.  
 The 2012 Virginia Comprehensive Cancer Control Program report provides an overview 
of cancer incidence, staging, mortality and screening disparities by race in Virginia 
(Comprehensive Cancer Prevention and Control Project, 2012).  Cancer incidence, based on 
2007-2011 Virginia Cancer Registry data, was similar between African-American women (128.9 
per 100,000) and White women (125.5). This does not follow the national trend whereby white 
women outpace African-American women in breast cancer incidence rates. Despite higher 
mammography screening rates (81% versus 78%), African-American women were more 
frequently diagnosed beyond a local stage and had a 39% higher mortality rate compared to their 
white counterparts (VDH, 2014).   
 Although significant gains have been made in improving screening rates across racial and 
ethnic groups, in part perhaps due to the NBCCEDP, disparities in breast cancer mortality 
continue to be evident.  An extensive review of the literature, focused on racial disparities in 
breast cancer mortality, was conducted by Wheeler, Reeder-Hayes and Carey (2013).  The 
researchers acknowledge many complex and overlapping factors contribute to breast cancer 
mortality disparities in the US. Despite decades of focused initiatives to remove barriers to 
screening, improve treatment regimens and provide necessary follow up, racial disparities in 
breast cancer mortality continue. Beyond tumor biology differences and other fixed factors such 
as race and age, disparities are also influenced by social and health system determinants. 
Wheeler et al. (2013) recommend clinicians, researchers and policymakers alike consider the 
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factors influencing breast cancer treatment and outcomes when developing future strategies to 
minimize or eliminate breast cancer disparities. 
The Impact of National Legislation and Policy 
 Due to these reported disparities in breast cancer screening and mortality, coupled with a 
favorable political climate, the National Breast and Cervical Cancer Mortality Prevention Act 
was passed as part of the Women’s Health Equity Act of 1990 (Breast and Cervical Cancer 
Mortality Prevention Act of 1990, 1990).  The Women’s Health Equity Act of 1990 created a 
package of proposed legislation aimed to expand research, health care access and disease 
prevention activities specific to women, including the NBCCEDP. Although the NBCCEDP 
funds mammography screening, the NBCCEDP does not offer funds to those diagnosed with 
cancer for treatment, creating what Lantz termed a “treatment gap” (Lantz, Weisman and Itani, 
2003). In response to this gap, along with substantial lobbying efforts from the National Breast 
Cancer Coalition (NBCC), the 106
th
 Congress passed the Breast and Cervical Cancer Prevention 
and Treatment Act of 2000 (Breast and Cervical Cancer Prevention and Treatment Act of 2000, 
2000). Through Medicaid eligibility expansion, the Breast and Cervical Cancer Prevention and 
Treatment Act (BCCPTA) provides health care coverage for the treatment of women diagnosed 
with cancer through the NBCCEDP. 
 Lantz, Weisman and Itani (2003) analyzed the BCCPTA through document analysis and 
semi-structured interviews of central figures (i.e. CDC representatives, advocacy and lobbying 
organization personnel and legislative staffers) involved in the process. The authors were 
prompted to conduct this investigation due to four unique reasons: 1) the legislation expands 
Medicaid eligibility based on a cancer diagnosis rather than particular income level; 2) all health 
care needs are covered for those diagnosed with cancer through the NBCCEDP; 3) the BCCPTA 
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addresses a gap that was created by previous legislation to screen underserved individuals 
without providing resources to obtain appropriate treatment, and 4) the BCCPTA was largely 
championed by the National Breast Cancer Coaltion (NBCC), a non-profit, advocacy group 
organized in 1991 that continues to actively pursue pathways to cure breast cancer. To fill a 
similar gap, President George W. Bush signed PL107-121, The Native American Breast and 
Cervical Cancer Treatment Technical Amendment Act of 2001, which allows women eligible for 
Indian Health Services to be included in the BCCPTA. 
 The Healthy People initiative, established by the U.S. Department of Health and Human 
Services, has evolved since 1990, but its’ primary goals remain to improve the overall health of 
U.S. residents and to eliminate health disparities. Healthy People 2010 established a goal of 70% 
of women ages 40-74 to be screened for breast cancer. With the goal unmet, Healthy People 
2020 refined the goal, aiming for a ten percent improvement in breast cancer screening among 
50-74 year old women (USDHHS, 2013). 
 Continuing this trend of focused attention on the health of the nation, historic legislation 
was passed March 23, 2010 in the form of the Patient Protection and Affordable Care Act 
(ACA).  The core elements of the ACA align with HP2020 objectives, including those specific to 
improved access to breast cancer screening. The ACA aims to increase access to cancer 
screening services through expanded insurance coverage and the elimination of cost-sharing 
(CDC, 2013). The CDC notes that even with screening programs, many women still face barriers 
such as geographic isolation, limited literacy, lack of provider recommendation, limited self-
efficacy, inconvenient facility hours, and language barriers (CDC, 2013). Though the legislation 
was passed in 2010, full implementation was not expected before 2015. Now, in 2015, most 
provisions of the law have been operationalized. 
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 The National Prevention Council, borne out of the ACA, is comprised of 17 federal 
departments and chaired by the Surgeon General. As part of a National Prevention Strategy 
(NPS), developed by the Council, four strategic directions were established to guide efforts 
toward a “prevention-oriented” society. The four areas of focus are: 1) healthy and safe 
community environments, 2) clinical and community prevention services, 3) empowered people 
and 4) elimination of health disparities (National Prevention Council, 2010). The NPS calls for 
partners in prevention (community coalitions) to change the country’s focus to prevention and 
wellness. The strategy establishes key indicators and provides evidence-based recommendations 
for each. The NPS works cooperatively with HP2020 to achieve ten year benchmarks with a 
singular goal and that is, to increase the number of Americans who are healthy at every stage of 
life (NPC, 2010).  
 Plescia and White (2013) use the NPS framework to guide a discussion about the future 
of breast cancer screening. While providing background information about NPS, the authors use 
the four strategic directions to build a case to improve breast cancer screening rates in this new 
era of health care reform. Breast cancer screening rates remain low in certain groups with one in 
four women, ages 50-74, without a mammogram within two years. Plescia and White (2013) 
identify promising methods of outreach and case management designed to reach traditionally 
underserved communities, such as the use of peer educators or patient navigators.  The authors 
draw from previous research to promote more patient-centered medical homes, educating and 
empowering consumers regarding the risks and benefits of breast cancer screening as a viable 
mechanism to encourage women to get appropriate screening. Further, the authors call upon 
public health leaders to use the NPS framework, along with the opportunity for increased 
participation through the ACA, to develop a national approach to control cancer. 
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National and State Breast Cancer Screening Programs 
 Using the social ecological model, the NBCCEDP is an example of how individual and 
population health outcomes are dependent on the coordination and interplay of social, 
organizational and policy influences. Administered by the CDC’s Division of Cancer Prevention 
and Control, the NBCCEDP operates in all 50 states, the District of Columbia, U.S. territories 
and tribal organizations. Eligibility criteria limit services to uninsured or underinsured women 
aged 40-64 who have incomes at or below 250% of the federal poverty level, though states may 
further restrict this criterion. Priority populations are identified as those never or rarely screened 
and women aged 50-64 years. According to 2011 data, NBCCEDP programs screened 
approximately 14.3% of eligible women, and have diagnosed more than 54,000 breast cancers 
since its inception in 1991 (CDC, 2012).  
 Adams, Breen and Joski (2006) presented a longitudinal data analysis of the impact of the 
NBCCEDP on breast and cervical cancer screening utilization among white, Hispanic and 
African American women using BRFSS data from 1996-2000. The authors limited their study to 
two economic variables (insurance and income) and two policy variables (longevity and state 
funding) among women aged 40-64 years. The researchers calculated odds ratios and predicted 
probabilities of screening by income level, insurance status, longevity of the program and state 
funding levels. The predicted probability of the uninsured receiving mammography is lower 
among white non-Hispanic women (26%) than African Americans (38.4%) or Hispanics 
(35.0%). A positive effect, a greater screening rate probability, was observed among white non-
Hispanic women based on the longevity of the state program. Though similar findings were 
observed in African American and Hispanic women, they were not statistically significant. 
Across all racial and ethnic groups, BRFSS data showed women that identify medical costs as a 
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barrier had lower odds of screening mammography regardless of insurance status. The reader 
should note this study was conducted prior to the Affordable Care Act which when fully enacted 
guarantees free breast cancer screening services to age appropriate women (Patient Protection 
and Affordable Care Act, 2010). 
 Though established in 1991 to increase screening among low-income women, the CDC 
made recommendations to improve the program in 2000 as reported by Lawson, Henson, Bobo 
and Kaeser (2000). During the first ten years, the NBCCEDP provided more than one million 
mammograms to under or uninsured women with 48% provided to racial or ethnic minorities. 
Funding allows approximately only 15% of the eligible women in the U.S. to utilize these 
services.  This remains a challenge of the program today. To maximize the use of resources, the 
NBCCEDP targets those women who have rarely or have never received a mammogram and 
women aged >50 years. The CDC set goals in four areas of focus: 1) screening initiatives, 2) 
case-management services, 3) professional education and training and 4) partnerships. To further 
these initiatives, the CDC developed a research agenda aligned with these same priority areas. 
The CDC continues to refine goals for the NBCCEDP based on current literature, legislation and 
data analysis. 
 Researchers Howard, Ekwueme, Gardner, Tangka, Li and Miller (2010) evaluated the 
impact of the NBCCEDP on breast cancer mortality rates based on 1990-2004 data. Their study 
was limited to women ages 40 to 64 years. The initial legislation that led to the development of 
the NBCCEDP was focused on the reduction of breast cancer mortality by improved screening.  
Early detection, diagnosis and treatment of cancer are associated with improved outcomes, 
including improved survival or conversely, decreased mortality. Using state level data, some 
evidence supports that the NBCCEDP led to a decrease in breast cancer mortality rates. 
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Specifically, there were 0.6 fewer breast cancer deaths for every 1000 women screened ages 40-
64 years. Because they were unable to detect an effect for future years, the authors caution 
against using this data as strong evidence of program effectiveness. 
 Using a breast cancer simulation model, Hoerger, Ekwueme, Miller, Uzanangelov, Hall, 
Segel et al. (2011) evaluated NBCCEDP data between 1991 and 2006. Separate simulations were 
designed and performed for women who received mammograms through the national screening 
program, those that may have been screened without the program and those not screened at all. 
The authors’ model indicated the program saved 100,800 life-years compared to those screened 
without the program and 369,000 life-years when compared to women without screening. Data 
suggest the NBCCEDP has reduced cancer deaths among 40-64 year old, medically underserved, 
low-income women.  
 While Hoerger et al. (2011) and Howard et al. (2010) focused their research on the 
impact of the NBCCEDP on breast cancer mortality, Escoffery, Kegler, Glanz, Graham, Blake, 
Shapiro et al. (2012) interviewed program recruitment coordinators in an effort to inventory and 
assess recruitment activities within the NBCCEDP programs. The interviews were conducted in 
2008 to ascertain recruitment activities, use of evidence-based strategies aimed to improve 
community participation as well as barriers to such strategies. Recruitment activities (n=340) 
were categorized and two thirds were found to adhere to an evidence-based intervention (EBI).  
Barriers to using EBIs included funding shortfall, limited staffing, and questionable usefulness to 
priority populations. The authors recommended additional training and technical assistance for 
participating NBCCEDP agencies to improve compliance with evidence-based strategies and 
ultimately, increase participation of priority population women. 
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 Virginia operates the NBCCEDP through its Every Woman’s Life (EWL) program 
(Virginia Department of Health [VDH], 2013).  Partnering with 32 enrollment sites, the EWL 
has provided 71,738 mammograms since 1998 (VDH, 2013). To be considered eligible for 
Virginia’s Every Woman’s Life federally funded breast cancer screening program, participants 
must be residents of Virginia, have incomes at or less than 200% of the Federal Poverty Level, 
have limited or no insurance and be between 40-64 years of age. State level data are available on 
the CDC website but are limited to the number of women served, screened and diagnosed along 
with demographic data, whereby the distribution of women receiving mammograms is provided 
by race/ethnicity and age groups (CDC, NBCCEDP Screening Program Summary-Virginia, 
2013). 
 Breast cancer continues to be a major health problem in the US and in Virginia.  The 
2010 five year incidence rates still placed Virginia (124.5 per 100,000/yr) ahead of the national 
average (119.8 per 100,000/yr).  Despite a vast pool of literature describing disparities in breast 
cancer screening and mortality, none are found using Virginia-specific NBCCEDP data. Current 
breast cancer data are derived from population surveillance surveys in combination with census 
data and national cancer databases. While these provide good estimates of breast cancer 
screening utilization and outcomes in Virginia, these data sources do not have the specificity to 
provide individual, regional and state level factors that influence breast cancer diagnoses in 
Virginia women who utilize the Every Woman’s Life Program. 
Preventive Health Behaviors 
 Preventive health behavior was defined by Kasl and Cobb (1966) as “any activity 
undertaken by a person who believes himself to be healthy, for the purpose of preventing or 
detecting illness in an asymptomatic state.” Preventive health behaviors are broad in scope, and 
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may include diet, exercise, smoking cessation and cancer screenings, including mammography. 
Under the umbrella of preventive health behavior, there is much research and subsequent 
literature focused on health information seeking behaviors. In order to effect behavior change, 
messages must be received and understood. Physician or providers have long been documented 
as the primary and most trusted source of health information (Schueler et al., 2008; Lemkau & 
Grady, 1998; Beaulieu et al., 1996). Literature suggests trusted sources of information vary 
among different socioeconomic and demographic groups. 
 Rains (2007) used data from Health Information National Trends Survey (HINTS) to 
evaluate both traditional and new sources of information, such as the World Wide Web (AKA 
the “Internet”). The results of the study suggest those distrustful of the information received from 
their providers also rated online health searches as “useless.” Trust was identified as a key 
element for an individual to find health information useful. 
 In an extensive review of the health information seeking behavior literature, Cutilli 
(2010) concluded that many factors influence an individual’s search for health information. 
Cutilli (2010) cited literature suggestive that the most trusted source of health information for 
African Americans is the health service professional. This coincides with findings from the 
qualitative study by Clark et al. (2014) that reported Black women of low socioeconomic status 
trusted physicians but sought additional sources of information to verify that information and 
support their health decisions. Other findings Cutilli (2010) summarized from the literature were 
that while older individuals utilized the Internet for information, decisions were made primarily 
with their physicians. Similarly, Hispanics and those with less education used supplemental 
sources of information (friends/family and TV/radio, respectively) to support their health 
decisions. 
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 Utilizing both the 2005 and 2007 HINTS data, Redmond et al. (2010) sought to 
determine what source of information was associated with cancer screening behaviors. In this 
study, “mass media” was defined as the Internet, TV, and print media while the second category, 
“interpersonal,” included health care providers and social networks. Though the most frequent 
source of health information among the 2005 survey respondents (n=5367) was friends and 
family, this was not predictive of meeting recommendations for health behaviors (diet, exercise, 
cancer screening). Across all respondents, those using print media (mass media) and community 
organizations (interpersonal) for health information were most likely to achieve health behavior 
benchmarks.  
 A 2003 study by Dutta-Bergman specifically investigated trusted online sources of health 
information. Though the personal doctor, medical university and federal government were found 
to be the most trusted online sources of information, Dutta-Bergman found significant 
differences across sociodemographic variables. Those with less education trusted the local 
hospital, while those with more education and higher incomes identified medical university and 
federal government websites as their most trusted sources of information. 
Smith (2011) provides a straightforward analysis of data from the 2008 Anneberg 
National Health Communication Survey to evaluate the relationship between various 
sociodemographic factors and the use and trust of health information sources. The survey 
(n=3656) found significant differences exist when examined by sociodemographic variables 
(age, race/ethnicity, gender, level of education, household income, health status).  Source of 
health information varied significantly by age groups. The oldest age group (>60 years old) was 
the most likely to trust health care providers, whereas the youngest group (18-29 years old) was 
the most likely to trust family and friends. Television and the Internet were the most trusted 
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sources of health information among adults 45-59 years of age, and 30-44 years of age, 
respectively.  The study found Whites, those with higher education and those with higher income 
levels were the most likely to use health professionals as the primary source of health 
information. Conversely, Blacks/African Americans, those with lower levels of education and 
those with lower income were more likely to use television. Family and friends were most often 
identified as trusted sources of health information among Hispanics, those with less education, 
and those with less income. Those most vulnerable to poor health outcomes (racial/ethnic 
minorities, low SES and less education) were the least likely to use health professionals for 
health information. 
 In a cross-sectional survey (n=157), Kratzke, Wilson and Vilchis (2013) studied rural 
women in New Mexico to explore health information seeking behaviors and their use of the 
Internet, cell phones and text messaging. Descriptive statistics highlighted television (58%) and 
magazines (46%) as the most utilized channel sources of obtaining breast cancer prevention 
information with the Internet (23%), brochures (23%), health fairs (22%), radio (13%) and 
newspaper (6%) completing the field. By a wide margin, the doctor (82%) was the most widely 
reported interpersonal source of breast cancer prevention information in this same group. Nurses 
(16%), clinic staff (21%), friends (10%) and family (8%) were among the others reported in this 
category. With a mean age of 60, most (87%) used cell phones and 47% reported to use text 
messaging. Where access to care may be limited, expanded strategies for communicating health 
care information for rural women may need to be tailored and may include cell phone and text 
messaging.  
According to the National Academy of Science publication, Speaking of Health:  
Assessing Health Communication Strategies for Diverse Populations, significant health 
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disparities persist and are expected to increase with the increase in population diversity in the US 
if effective actions are not implemented. Effective communication relies on understanding 
cultural and social differences that influence health behaviors among individuals, families and 
communities (National Research Council, 2002). Health educators, policy makers, and program 
administrators need to be aware of trusted sources of health information to deliver effective, 
tailored messages across Virginia to increase utilization of preventive health services. 
 These findings about trusted sources of health information are indicative of the varied 
and complex decision-making processes individuals must consider when engaging in preventive 
health behaviors, like breast cancer screening. Though ultimately an individual choice and an 
individual action, the groundwork to provide an impetus for action and access to services occurs 
on multiple fronts. Beyond education for the individual or community, modern health promotion 
depends on the successful interaction of government, state and regional entities to provide 
economic and structural support. The ecological perspective, while focused on the “big picture”, 
stresses the importance of the integration of these factors (Rimer & Glanz, 2005).  
Theoretical Framework 
 This is an expanded presentation of the socioecological model (SEM) as it pertains to this 
research. This theoretical framework is well-suited to account for the complex, intermingled 
layers of influence associated with a woman’s decision and opportunity to obtain a screening 
mammogram.  Ecological is defined as “organisms in an environment.” The SEM is rooted in 
child development theory originally proposed by Bronfenbrenner in 1978. Bronfenbrenner 
developed the model to address micro to macro influences on children and their place within 
families, communities, and society (Bronfenbrenner, 1979). McLeroy, Bibeau, Steckler and 
Glanz (1988) first proposed the SEM for health promotion programs to move away from life-
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style focused change theories where victim-blaming had become common. The model, as 
depicted in Figure 1.0, continues to incorporate individual or intrapersonal factors such as 
knowledge, attitudes and beliefs but adds social and environmental factors outside the 
individual’s level of influence. In addition to the individual factors, the SEM described by 
McLeroy et al. (1988) adds interpersonal, institutional, community and public policy factors as 
major influences. Interpersonal factors are comprised of an individual’s social network, which 
may include trusted sources of health information such as health care providers, patient 
navigators, community health workers as well as family and friends. Health care systems and 
service providers, on the other hand, would be considered institutional or organizational factors. 
The EWL program and its many community partners would be categorized as organizational 
factors.  Community level factors may include health fairs, media campaigns, employer 
initiatives and health promotion programs. Finally, the public policy layer of influence may be 
the most removed from the individual but may have the greatest influence. Public policy 
supports health initiatives with financial along with other important resources. This particular 
model is well suited for this research as influencing factors are considered at multiple levels.  
 Rimer and Glanz (2005) in the second edition of Theory at a Glance: A Guide for Health 
Promotion Practice identify two key principles of the ecological perspective.  First, behavior 
affects and is affected by multiple layers of influence as described by McLeroy et al. (1988). 
Second, a concept termed “reciprocal causation,” is where individual behavior shapes and is 
shaped by the social environment in which the individual exist. 
 Intrapersonal or individual factors of the SEM include knowledge, attitudes and beliefs 
(KAB) as well as biological and economic factors. There is a plethora of literature devoted to 
KAB about breast cancer and breast cancer screening, largely stratified by race, ethnicity, SES or 
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geographic locale. Adequate knowledge, positive attitudes and beliefs may only result in action 
if an individual has some level of self-efficacy. This is generally described as the confidence in 
one’s ability to take action (Bandura, 1977). A study (n=194) by Allen, Sorensen, Stoddard, 
Colditz and Peterson (1998) revealed that self-efficacy and strong social support were 
significantly related to an individual’s intention to have a mammogram. The authors 
recommended health program planners use interventions that build women’s confidence to 
discuss mammography with health providers. Self-efficacy is at the core of the social ecological 
model, though not explicitly described. An individual’s intent to have a mammogram will fail 
unless access to affordable and convenient breast cancer screening services are available. 
 Individual behavior is influenced by one’s knowledge, attitudes and beliefs as well as the 
influences of others with which the individual identifies. Allen et al. (1998) recommended 
interventions among social networks may promote mammography use.  This recommendation 
addresses the second, interpersonal level of the SEM. The social network includes friends, 
family, coworkers, health professionals and others, according to Rimer and Glanz (2005). At this 
level, providers make screening recommendations to their patients and community health 
workers or patient navigators work to remove barriers to screening. Beyond the individual and 
their social (interpersonal) network resides the organizational level of influence. The EWL 
program is an example of a prevention activity implemented at the organizational level. With 
coalition partners throughout the Commonwealth, the EWL program provides structure and 
support for breast cancer screenings.  
 Beyond the organizational level activities resides the community level of influence. 
Media campaigns and community health programs are representative of interventions appropriate 
at this level (CDC, 2013). Structure and financial resources to conduct such screening 
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interventions are generally provided by the outermost level of influence, public policy. For the 
EWL program, Public Law 101-354 and subsequent legislation continues to provide necessary 
structure and support.   
 SEM has been embraced by governmental agencies and is used for the CDC’s National 
Breast and Cervical Cancer Early Detection Program (NBCCEDP) and US Department of Health 
and Human Services’ Healthy People 2020 initiative. The model addresses the institutional, 
community and policy levels of influence on public health, improving our ability to reach more 
people. Lieberman, Golden and Earp (2013) raise questions regarding the effectiveness as well 
as the ethics of endorsing structural approaches to health promotion. The authors caution that 
structural approaches may help eliminate health disparities, but only if offered in and embraced 
by traditionally medically underserved communities with the greatest need. The EWL program is 
specifically designed to meet this need. 
 Mittler, Martsolf, Telenko and Scanlon (2013) address both policymakers and 
practitioners to improve health care through consumer engagement initiatives using a 
combination of the SEM and the transtheoretical model of individual behavior. The authors 
describe consumer engagement in health care as two-pronged: “engaged” or performed 
behaviors and “activation” or capacity to perform behaviors (Mittler et al., 2013). The authors 
used this theoretical framework to analyze an existing community engagement program, 
classifying targeted behavior types as well as individual, group and community influences. 
Mittler et al. (2013) propose their framework as a structured method to evaluate pre-existing 
programs for policymakers and practitioners by alerting them to various influences that may 
impact future program goals. 
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 Findings from this research provide unique feedback for the EWL program and its 
community partners. Early detection is a primary initiative of the NBCCEDP with the targeted 
behavior being the screening mammogram. This study reports early detection rates, stratifies 
trusted sources of health information by level of influence and explores various 
sociodemographic and preventive health behaviors that may influence health outcomes of 
women that utilize the EWL program. 
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CHAPTER 3 
METHODOLOGY  
 
Introduction 
This chapter provides a summary of the methods and procedures used to address the 
research questions. It includes the research problem, research design, research questions, source 
of data, unit of analysis, variables, and data analysis. This research was approved by the Virginia 
Commonwealth University Institutional Review Board (IRB) Appendix A. Additionally, IRB 
approval was obtained from the Virginia Department of Health with a written Data Use 
Agreement (Appendices B and C). 
Research problem  
Breast cancer continues to be a health risk in the United States, with a 12% lifetime risk 
among women (ACS, 2015). The 2005-2012 incidence of breast cancer in Virginia (124.0 cases 
per 100,000) closely match the national average of 124.3 cases per 100,000. While breast cancer 
incidence between white and African-American Virginians are comparable (124.2 and 126.1, 
respectively), disparities in survival exist with African American women experiencing a 40% 
higher mortality rate than their white counterparts (VDH, 2014). Early detection is closely linked 
with improved survival when diagnosed at an early stage. Virginia Cancer Registry statistics 
from 2005-2012 indicate white women (63%) were more likely to be diagnosed with a local 
stage of breast cancer than African American women (53%) during that same timeframe. 
Frequently encountered in the literature, income is intermingled with other variables and is 
reported on census-tract level whereas these data provide self-reported individual-level incomes. 
Education is found as a proxy for SES (Council on Virginia’s Future, 2015). Beyond income, the 
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term “socioeconomic status” incorporates factors such as occupation, education and housing to 
complete the picture. Sapolsky (2005) and others have recognized that “starting with the 
wealthiest stratum of society, every step downward in SES correlates with poorer health.” As 
established per federal policy and state eligibility requirements, the entire sample studied are 
considered low income or low SES. Do breast cancer disparities persist among this group of 
women? How does this population of women discover affordable breast cancer screening 
opportunities? Findings or the absence of significant findings from this state and regional 
specific data analysis may inform the work of providers, program administrators, community 
partners and policy makers.  
Design 
This non-experimental, descriptive study explored existing data from the Cancer 
Statistics and Tracking (CaST) system which maintains the Every Woman’s Life (EWL) client 
information by the Virginia Department of Health (VDH). The intent of the research was to 
explore the relationship of various sociodemographic determinants of health and preventive 
health behaviors, on an individual’s breast cancer diagnosis, breast cancer stage at the time of 
diagnosis and their source of information to the EWL screening mammography program. 
Thousands of uninsured and underinsured women have secured mammograms through this 
program since its inception in 1997.  
Research questions  
  Within the parameters of data from the Virginia Department of Health’s Every Woman’s 
Life program database, what factors can be identified that may affect breast cancer diagnoses 
among low income women 40-64 years old?  
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RQ1.  What is the association between socio-demographic determinants (race, age, income, 
education, language and geographic location) and prior mammography and cancer diagnosis 
among women 40-64 years of age utilizing EWL services? 
RQ2. What is the association between socio-demographic determinants (race, age, income, 
education, language and geographic location) and prior mammography and cancer stage at 
the time of diagnosis among women 40-64 years of age utilizing EWL services? 
RQ3. What is the association between socio-demographic determinants (race, age, income, 
education, language and geographic location) and source of information among women 40-
64 years of age utilizing EWL services? 
Source of the data 
The Virginia Department of Health is a state government agency. The EWL program 
operates under the Office of Family Health Services and within the Division of Prevention and 
Health Promotion (VDH, 2015). The EWL program began in 1997 utilizing NBCCEDP funds to 
provide low-income women access to breast and cervical cancer screening to promote early 
detection. Current funding of the program allows approximately 10% of the eligible population 
to receive free screenings. Published priority populations include minorities, economically 
deprived and women over 50 years of age (VDH, 2015). There are 32 EWL enrollment sites 
across the state that coordinates with approximately 250 healthcare providers to obtain clinical 
services. 
Data source 
  Secondary data analyses of the VDH Every Woman’s Life Cancer Statistics and 
Tracking (CaST) database examined the association of various sociodemographic determinants 
and preventive health behaviors on breast cancer diagnosis and stage at the time of diagnosis. 
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Along with demographic elements (age, race, county of residence, and primary language), the 
data set included two health behaviors (prior mammogram and smoking status). Measures of 
socioeconomic status represented in the data set included income, the number of persons living 
on that income, as well as the highest level of education attained. The date and site of enrollment 
were provided, along with the mechanism for hearing about the EWL program. Finally, there 
were multiple variables related to breast cancer, including the final diagnosis, tumor histology 
and staging information. The CaST database included 98,250 records of women who enrolled in 
the Every Woman’s Life program from 1998 to 2012. This included 57,763 records with 
duplicate unique identifiers representing women who obtained more than one mammogram 
during this same timeframe. For these repeat users, only the initial entry was retained for 
analysis. An additional 5,545 records were excluded for those outside of the age or federal 
funding source requirement. The resulting sample size for this study was 34,942 Virginia women 
between the ages of 40-64 who utilized mammographic services funded through the NBCCEDP 
in the 1998-2012 timeframe. 
Variables 
Outcome or dependent variables in the study include the diagnosis of breast cancer, the 
stage at the time of diagnosis and information source. Predictor or independent variables include 
the sociodemographic determinants of age, race, education, income, geographic locale, language 
and a preventive health behavior, receiving a prior mammogram. A second preventive health 
behavior, intent to stop smoking, was removed from the model as it was found to reduce the 
number of cases in the analysis to less than ten. Upon receipt of the data, each parameter was 
verified prior to importing into IBM SPSS® Statistics 23 software package. Initial analysis of the 
study variables determined frequencies and aided in subsequent allocation strategies.  
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Dependent variables in the first two research questions are “a breast cancer diagnosis” 
and the “stage at the time of diagnosis”, outcomes central to the mission of the EWL breast 
cancer screening program. Both of these dependent variables are categorical. Breast cancer 
diagnosis is a dichotomous categorical variable with only two discrete possibilities where 
participants either are or are not diagnosed with breast cancer. The intent, prior to data analysis, 
was to treat stage at the time of diagnosis as a dichotomous variable with “early stage” and “not 
early stage” as the two levels. Early stage was to be defined, in alignment with National Cancer 
Institute guidelines, as those with Stage 0, I, IA, IIA, IIB or IIIB breast cancer. All others were to 
be categorized as “not early” for the purposes of this study. However, AJCC staging completed 
for only 40% (460/1143) of those diagnosed with breast cancer forced an alternate categorization 
scheme. Using the EWL supplied “breast final diagnosis,” complete for 100% of those 
diagnosed, staging was then assigned as either “Stage 0” or “invasive”. Stage 0 was comprised of 
those diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS), both 
considered to be non-invasive (ACS, 2015).  Those identified as “invasive” were assigned into 
the category by the same name.  In research question three, the dependent variable is “source of 
information” was categorized as either provider or non-provider, based on responses to the 
question, “How did you hear about the EWL program?”  Documented preferred sources of health 
information and referral are varied in the literature with Smith (2011) finding older adults, 
Whites, those with more education and higher incomes more likely to trust health professionals 
as trusted sources of health information. Sources of health information and referral within the 
EWL sample extend into each level of the socioecological model as individual responses ranged 
from “self” (individual), “nurse, family, friend” (intrapersonal), “health clinic” (organizational), 
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and “radio/TV/newspaper” (community)  though in the final analysis these categories were 
collapsed into provider and non-provider to align with the literature.  
Independent variables were selected based on the review of the literature. Categorical 
independent variables included race, as defined by the Office of Budget and Management 
Statistical Policy Directive No. 1, (0=White, 1=Black/African American, 2=American 
Indian/Alaska Native, 3=Asian, 4=Pacific Islander/Native Hawaiian, 5=unknown), income level 
(0=200% FPL, 1=150% FPL, 2=100% FPL), geographic location (VDH health districts, coded 
1-35 in alphabetical order), language (0=English, 1=Spanish, 2=Other/IndoEuropean, 
3=Asian/Pacific Islanders, 4=Other) as defined by the “Primary Language Code List” published 
by the US Census Bureau (Appendix F), and education (0=<9
th
 grade, 1=Some high school, 
2=High school graduate or equivalent, 3=Some college, 4=Unknown) predetermined from the 
self-reported client eligibility form. Self-reported income, along with the answer to “How many 
people live on this income including yourself?” was used to construct and stratify income levels 
(200%, 150% and 100% FPL) based upon historical federal poverty level guidelines (Appendix 
G), which varied annually.  Virginia has 35 established health districts. The 2007 American 
Community Survey (Bishaw & Semega, 2008) identifies Fairfax County among the top ten 
wealthiest counties, based on median household income, in the United States. To provide a 
meaningful comparison among health districts, the Fairfax health district was selected as the 
reference group in the analyses. Based on city or county of residence, participants were assigned 
to their appropriate health district (Appendix H). Subsequently, participants were parsed into 
their respective EWL regions (Northwest, Northern, Central, Southwest and Southeast) by 
“enrollment location” to use when sample size dictated a collapse in variable stratification, 
recognizing this sacrifices variability. The use of five EWL regions, rather than 35 health 
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districts, was used for the analyses for research question two. Similarly, the same was done for 
race (0=White, 1=Black/African American, 2=All others) and language (0=English, 1=All 
others). Age was treated as both a continuous variable (40-64) and categorical variable (40-49, 
>50) in the analyses, requiring two separate models. Age as a continuous variable provided full 
information and maximum variability. The decision to create a binary categorical age variable 
with a division at 50 years of age was based on the USPSTF recommended age to initiate breast 
cancer screenings and the EWL’s recommended age threshold for priority screening recruitment 
efforts (VDH, 2012). Having a prior mammogram was coded (0=No, 1=Yes, 2=Unknown) 
according to self-reported information on the client eligibility form. The study variables are 
further identified and categorized in Table 3.1. 
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Table 3.1         Study Variables     
Name of Variable Type of Variable Categories 
Dependent Variables 
  Breast Cancer Diagnosis Categorical Yes/No 
   Breast Cancer Stage Categorical Early/Not Early 
   Source of information Categorical Provider/Non-provider 
   Independent Variables 
  Sociodemographic determinants     
 
Race 
 
Categorical 
White, Black, Asian, American 
Indian/Alaskan, Native Hawaiian/ 
Pacific Islander, Other  
   Age Continuous 40-64 
 
Categorical 40-49, 50+ 
   Education Categorical <9th grade, some high school, high 
school graduate or equivalent, some 
college or higher, unknown 
   Income Categorical 200% FPL; 150% FPL; 100% FPL 
   Geographic locale Categorical 35 Virginia Health Districts 
   Language Categorical English, Spanish, Indo-European, 
Asian/PI, Other 
    Preventive Health Behaviors     
   Prior Mammogram Categorical Yes/No/Unknown 
      
 
Unit of analysis 
The unit of analysis was women who utilized federal funding for mammographic 
screening services through the EWL program. Program eligibility requirements specify 
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participants to be a certain age (40-64), residents of Virginia, born female, incomes at or less 
than 200% FPL, with limited or no insurance (VDH, 2015). A census sample of all women who 
initiated a “breast cycle” in calendar years 1998 to 2012 was obtained from the VDH in an 
Excel® spreadsheet format. Selected parameters of the EWL database included:  date of birth, 
race, language, county of residence, enrollment site, income (and number of persons in the 
household), level of education, prior mammogram, smoking status, source of EWL information, 
final diagnosis and stage at the time of diagnosis. With the exception of final diagnosis and 
staging information, the elements are self-reported by the participant using a client eligibility 
form (Appendix E). The client eligibility form has a combination of open-ended and structured 
questions.  
Data Analysis 
 Descriptive and multiple logistic regression statistics were the method of statistical 
analyses conducted using IBM SPSS® 23 software. Descriptive statistics included frequencies 
and cross-tabs which were important in identifying missing cases as well as establishing coding 
strategies and referent groups for the regression analyses. A correlation analysis was performed 
to assess covariance or conversely, the independence, among the variables. Correlation 
coefficients, between negative one and positive one, describe the direction and strength of the 
relationship that may exist among variables (Field, 2009, p.783). Independent variables with 
statistically significant relationships with the dependent variables were included in the statistical 
model. 
 Inferential statistical analyses were conducted to address the research questions. The 
results, with an appropriate level of caution based on power and effect size, allow inferences to 
be drawn about a population based on the sample data. Logistic regression is the statistical 
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analysis best suited for the focus of the research questions, as the dependent variables are 
categorical and the predictor variables are either continuous or categorical (Field, 2009). Logistic 
regression is widely used in health sciences research with the primary aim of developing the best 
model to describe the association between the dependent and independent variables. Specifically, 
logistic regression was conducted for research questions one, two and three since the dependent 
variables (breast cancer diagnosis, breast cancer stage and source of information) are 
dichotomous.  
Through the logarithmic (logit) transformation of the linear regression model, logistic 
regression allows non-linear relationships of categorical data to be expressed in a linear way. In 
logistic regression, the analysis provides the probability (between zero and one) of the dependent 
variable occurring rather than predicting the actual value of the dependent variable as in linear 
regression. A value close to zero means the outcome (dependent variable) is unlikely to occur 
whereas a value close to one means the outcome is very likely to have occurred. An odds ratio 
(OR) is a measure of the likelihood of an outcome occurring among those with a particular 
independent variable compared to a referent group. Odds ratio help provide meaningful 
interpretation of logistic regression results, as it approximates relative risk (Hosmer, Lemeshow 
& Sturdivant, 2013). 
To build the best fitting logistic model, independent variables were assessed for 
collinearity, interactions, confounding and ultimately, significance. Decisions to include or 
exclude each variable in the model were informed by the literature and statistical analyses. 
Bivariate analyses were conducted to test each independent variable’s association with the 
dependent variable (main effect). The Wald chi-square statistic was used to assess significance, 
where a large Wald score represents a significant contribution in the model. Collinearity is not 
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desirable among independent variables. As collinearity increases, it becomes more difficult to 
assess which variable is responsible for changes in the outcome (dependent variable). Correlation 
coefficients were used to examine the collinearity among independent variables. According to 
Allison (2012), a correlation with Pearson coefficient (R)
2
 of .6 should be considered for 
exclusion from the model, though there is no explicit rule for the cut-off value. The researcher 
tested for main effects between each of the independent variables with the dependent variable. 
Lastly, for variables not found to be effect modifiers, confounding was evaluated. Upon initial 
regression analysis, the independent variables were evaluated for confounding factors. If the 
odds ratio changes more than 10% between the crude and fully adjusted (stratified) model, the 
variable is considered a confounder and is to be included in the final model. When confounding 
is present, the relationship between the independent and dependent variable is “distorted” 
because of the impact of a third variable (Aschengrau & Seage, p. 288). An odds ratio greater 
than one means the odds of the outcome occurring increase. All independent variables, except 
age, were found to be confounders where there was a greater than 10% change between the crude 
and fully adjusted odds ratios. Both crude and fully adjusted odds ratios are presented, as is 
common in epidemiologic research. Confidence intervals and p-values are reported to provide 
additional information about the role of chance in the results. Logistic regression models were 
built for each of the research questions using these methods of including or excluding variables. 
The log likelihood statistic (-2LL) is used to assess the fit of the logistic regression model. It is 
desirable to have a small value, representing a “good fit” where there is only a small amount of 
unexplained information (Field, p.267). There are multiple measures of significance that may 
also be used to evaluate the significance of the model including, the Hosmer and Lemeshow 
Test, Cox and Snell’s R2 , and Nagelkerke’s R2. Statistical power is the term used to assess the 
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ability to detect a significant relationship (Aschengrau & Seage, p.180). Power analysis is useful 
for study design though for a case, like this study, where the researcher is limited to the sample 
provided a sensitivity power analysis can be used to calculate effect size, assuming power level 
is pre-established (Hunt, 2015). To reveal small differences between groups, a large sample size 
is needed. Missing data, by reducing the effective sample size, decreases statistical power.  
Missing data reduced the available sample used in the statistical analysis for research 
question one whereby 62% (n=21,763) of the participants had left the question “What is the 
highest grade of school you completed?” unanswered. In post hoc analyses, chi-square tests were 
performed to compare the frequencies between those reporting an educational level and those not 
reporting an educational level. With all variables showing statistical significance, the same 
regression models for research question one were run for the women with no educational status 
reported in order to compare findings between the two groups. Additionally, it was decided to 
combine Pacific Islander/Native Hawaiian (n=13) with the Asian (n=652) race category for these 
analyses. This was reasonable, given Asian and Pacific Islanders were already combined for the 
language variable. Those results are reported in Chapter 4. 
Model assumptions  
According to Wright (1995) five conditions are needed for a logistic regression model to 
be valid. The first assumption requires the dependent variables to be dichotomous. The three 
dependent variables in this study (breast cancer, breast cancer stage, source of information) all 
meet this requirement. Second, there must be independence of observations where no individual 
appears twice. By checking for duplicate EWL unique identifiers, this assumption was met. The 
specificity assumption (third) dictates that only significant measures are included in the model. 
Though procedures were followed to test for individual variable contribution to the model, some 
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variables without statistical significance were kept based on their importance in the body of 
literature reviewed. The fourth assumption demands that within the variable strata there must be 
clear and exclusive group membership. That is, a case may not have membership in more than 
one category. Women receiving breast cancer screening mammograms either are or are not 
diagnosed with breast cancer, two separate and distinct classifications. Among those diagnosed 
with breast cancer, staging category strategies that were adopted place women in either the Stage 
0 (non-invasive) category or the invasive cancer category.  Lastly, Wright (1995) indicates larger 
samples are required for logistic regression when compared to linear regression analysis. He cites 
Aldrich & Nelson (1984) as prescribing a minimum of 50 cases per independent variable for 
improved accuracy in the model. With 34,942 cases, it was expected to meet this assumption. 
However, as will be discussed in Chapter 4, there were independent variables with insufficient 
representation in all strata which forced a reassessment and subsequent collapse of the variables 
response categories. 
Delimitations 
 This exploration of EWL data may illuminate meaningful relationships between the 
variables studied; however it is important to delimit any findings to the sample included in the 
study. These data are limited to the women who utilized the EWL breast cancer screening 
program in calendar years 1998-2012. It is assumed they met eligibility criteria. The VDH 
estimates funding by NBCCEDP provides free mammograms for approximately ten percent of 
eligible Virginia women. Additionally, the sample is delimited to geographic areas served by the 
32 EWL enrollment sites. 
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CHAPTER 4 
 
RESULTS 
 
 
 This focus of this chapter is to present a summary of the statistical findings. Females 
(N=34,942) included in the analyses were between the ages of 40-64 who received a federally 
funded mammogram through Virginia’s Every Woman’s Life program in calendar years 1998 
through 2012. Complete data for all desired measures were not available for the entire sample 
and adjustments were made as described in Chapter 3. Both descriptive and inferential statistical 
analyses are presented in this chapter. 
Demographics by age 
The average age of the sample was 53 years of age (Figure 4.1). There is a notable spike at 50 
years of age, coinciding with the USPTF’s recommended age threshold to start mammography 
screening and the published priority population for the Every Woman’s Life Program. When 
viewed by category, almost 75% (25,901) are 50 to 64 years of age while the remaining 25% are 
in the 40 to 49 age group. Table 4.1 displays sample demographics by age, race, language, 
education, geographic region, and income level. 
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Demographics by race 
The racial demographics of the participants were White (56.3%), Black (33.8%), Asian 
(4.3%), American Indian/Alaska Native (<1.0%), Native Hawaiian/Pacific Islander (<1.0%), and 
Other/unknown (5.0%).  
Demographics by language 
 In the sample, over 90% (31,640) identified English as the language spoken daily with 
Spanish (4.9%), Asian/Pacific Islander (3.2%), IndoEuropean (<1%) and all others (<1%) 
representing the remainder. When stratified by EWL region (Appendix I), the Northern region 
reports the most diversity with more than 50% of the participants speaking a language every day, 
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other than English. To further illustrate, Figure 4.2 displays languages, other than English, 
spoken within each region. 
 
 
Figure 4.2 Non-English language frequencies by region 
 
Demographics by education 
 Over 60% of the participants left the question “What is the highest grade of school you 
completed?” unanswered, leaving approximately 40% to include in the initial analyses. In fact, 
education was removed from the regression model for research question two and three due to the 
aforementioned missing cases. Of the remaining participants 3.3% reported having completed 
less than 9
th
 grade, 5.6% some high school, 16.8% high school graduate or equivalent and 10.9% 
some college or higher and 2.3% unknown.  
Demographics by geographic region  
The Virginia Department of Health’s Every Woman’s Life Program divides the state into 
five regions, specific service areas are detailed in Appendix J. Geographically, the Southeast 
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region had the highest percentage of women (30.2%) represented in the sample followed by, the 
Northwest (24.6%), Southwest (24.3%), Central (10.7%), and Northern (10.1%) regions. 
Demographics by income level 
 Though all participants in the EWL program are by eligibility requirements considered 
“low income,” the sample was divided to differentiate levels of poverty and test their 
significance, if any. Federal poverty guidelines (Appendix G), published by US Health and 
Human Services, outlines the criteria which are adjusted annually. Within the sample, 77.2% 
were classified into the 100% times the published FPL for the year in which services 
(mammogram) was received. This group would be considered to have the least “wealth” among 
the participants. To complete the sample, 14.1% had income at 150% FPL with the remaining 
2.1% in the top tier at 200% FPL. 
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Table 4.1 Sociodemographics 
   
N=34942   n (%)
a
 
Age  
     40-49  
    
9041 (25.9) 
>50  
    
25901 (74.1) 
      Race 
     White 
    
19681 (56.3) 
Black 
    
11822 (33.8) 
American Indian/Alaskan Native 
 
185 (<1) 
Asian 
    
1513 (4.3) 
Native Hawaiian/Pacific Islander 
 
17 (<1) 
Other/unknown 
   
1724 (5) 
      Language 
    English 
    
31640 (90.6) 
Spanish 
    
1722 (4.9) 
IndoEuropean 
   
241 (<1) 
Asian/Pacific Islander 
  
1132 (3.2) 
All others 
    
150 (<1) 
      Education 
    <9th grade 
   
1164 (3.3) 
Some high school 
   
1972 (5.6) 
High school graduate or equivalent 
 
5860 (16.8) 
Some college or higher 
  
3794 (10.9) 
Unknown 
    
389 (1.1) 
Left blank 
   
21763 (62.3) 
      Geographic region 
    Northwest 
   
8605 (24.6) 
Northern 
    
3529 (10.1) 
Central 
    
3747 (10.7) 
Southwest 
   
8495 (24.3) 
Southeastern 
   
10566 (30.2) 
      Income levels 
    100% FPL 
   
750(2.1) 
150% FPL 
   
4941 (14.1) 
200% FPL 
   
32668 (93.5) 
Unable to calculate 
   
2274 (6.5) 
      a
 percentage may not equal 100% due to rounding   
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Logistic regression 
 The logistic regression model predicts the relationship between one or more independent 
variable(s) and the dichotomous dependent variable. Independent variables selected are 
evaluated for collinearity, confounding and interaction prior to inclusion in the regression model.  
Assessing frequencies and establishing stratification strategies are dependent on sample size and 
whether the variables are significantly correlated. Univariate analysis of each independent 
variable’s main effect established its importance within the model. Further, the interaction of two 
or more variables can also be assessed. Once independent variables are selected, the iterative 
process of fitting the regression model begins. 
The alpha level, commonly set at the 0.05 significance level, represents the probability 
(5%) of committing a Type I error where the researcher rejects the null hypothesis when, in fact, 
it is true. If an independent variable is found to have a p-value less than the preselected 
significance level, then it is meaningful and should be included in the regression model. Each 
regression coefficient (B) represents the change, in the form of a slope, the variable has in 
response to one unit of change in the dependent variable. The coefficient is specific to the 
individual independent variable, holding all other predictor variables constant. When the 
coefficient is large, the standard error (SE) increases as well. 
The Wald (X
2
) statistic provides another measure to estimate the unique contribution of 
each independent variable to the regression model. A large Wald statistic indicates it contributes 
largely to the model and should be included in the final regression analysis.  
The odds-ratios, Exp B, are reported with their respective 95% confidence intervals. A 
wide confidence interval indicates low precision whereas a small confidence interval provides a 
higher level of confidence. Reference groups were established to aid in the odds-ratio (OR) 
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interpretation. The odds ratio (OR) is another way to assess the strength of the relationship 
between the independent variable and dependent variable, as compared to the reference group. 
An odds ratio of 1 is assigned to the reference group. Therefore, an OR less than one indicates 
the relationship is less likely to occur and conversely, an OR greater than one indicates the event 
is more likely to occur.  
Measures provided in the SPSS regression output to assess the overall performance of the 
regression model include the classification table, -2LL, pseudo R squares and the Hosmer-
Lemeshow statistic. The classification table is used to estimate the percentage of occurrences 
correctly predicted by the model. The -2LL, which is the product of negative two times the log of 
the likelihood, is always a positive number. The smaller the -2LL number, the better the fit of the 
regression model is indicated. The two pseudo R squares, the Cox and Snell and the Nagelkerke, 
are used as effect size measures of the model. There is debate surrounding the use of pseudo-R
2
 
in logistic regression, since it was designed for linear regression analysis. The Hosmer-
Lemeshow statistic is used to assess goodness of fit of the model. The logistic regression model 
for research question one is as follows: 
              
Log (odds of having a breast cancer diagnosis)= -5.387 -.192*Race(Black)-.511*Race(American 
Indian/Alaska Native)-.171*Race(Asian)+1.681*Race(Native Hawaiian/Pacific Islander)+.050*Race(All 
others)+.049age in years+.129*Education(some high school)+.114*Education(high school graduate or 
equivalent)+.217*Education(some college or higher)+.564*Education(unknown)-
.099*Income(150%FPL)+.218*Income(200%FPL)-.125*Language(Spanish) +.620*Language 
(Other/IndoEuropean)-1.045*Language (Asian/Pacific Islander)+.104*Language(All others)-
.756*Health District(Alleghany)-.490*HD(Arlington)-.798*HD(Central Shenandoah)+.149*HD(Central 
Virginia)-.641(Chesapeake)-.379*HD(Chesterfield)-.223*HD(Chickahominy)-.722*HD(Crater)-
.997*HD(Cumberland Plateau)-1.107*HD(Eastern Shore)+.216*HD(Alexandria)-.160*HD(Hampton)-
.349*HD(Henrico)-2.230*HD(Lenowisco)-.797*HD(Lord Fairfax)+.271*HD(Loudoun)-
.938*HD(Mount Rogers)-1.084*HD(New River)-.475*HD(Norfolk)-.021*HD(Peninsula) 
+.484*HD(Piedmont)+.150*HD(Pittsylvania)-.544*HD(Portsmouth)-.591*HD(Prince William)-
.664*HD (Rappahannock) +.100*HD(Rappahannock Rapidan)-.339*HD(Richmond)-.292*HD(Roanoke) 
+.201*HD(Southside)-.601*HD(Thomas Jefferson)-.244*HD(Three Rivers)+.812*HD(Virginia Beach) 
+.121*HD(West Piedmont)+.087*HD(Western Tidewater)-.321*Prior mammogram(Yes)+.272*Prior 
Mammogram(unknown)where the odds=p/(1-p) and p is the probability  
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Research question one (breast cancer diagnosis) 
 
Research question one uses multiple logistic regression models to evaluate the 
relationship of the independent variables (age, race, language, education, geographic locale and 
prior mammogram) on the likelihood of breast cancer diagnosis within the sample. A large 
sample (n=12045) with complete data on the independent and dependent variables was available 
for analysis. Initial descriptive statistics were conducted and evaluated. The independent 
variables were assessed for collinearity. The correlation between variables was analyzed and is 
shown in Table 4.2.  
 
Table 4.2 
        Correlation between independent variables     
  
Race Age Education Income Language 
Prior 
mammogram 
Health 
district 
         Race 
  
-.019** -.056** .025** .475** -.048** -.055** 
Age 
   
-0.008 -0.006 -0.003 .108**       -0.003 
Education 
    
-.021* -.087** .051** .066** 
Income 
     
-.021** -.033** .027** 
Language 
      
-.096** -0.245** 
Prior 
mammogram 
       
.043** 
Health district 
                  
**Correlation is significant at the 0.01 level (2-tailed) 
    *Correlation is significant at the 0.05 level (2-tailed) 
     
 
Race and language shows a moderately positive correlation (r (34,942) = .475, p<.05). 
The remaining variables showed weak correlations, ranging from -.245 to +.108. No variable 
was significantly correlated with age except with “prior mammogram,” which showed a positive 
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correlation (r (34,942) = .108, p<.05). All other variables tested significant (p<.01) excluding the 
correlation between education and income level (p<.05).  
Interpreting the odds-ratio (Table 4.3) for each one year increase in age, women are 1.050 
times more likely to receive a breast cancer diagnosis. In a second model (Appendix K), using 
the 50+ group as a reference category (OR=1), the 40-49 year old group were 25% less likely to 
be diagnosed. Both of these were found to be statistically significant at p=<.05. The odds-ratio 
demonstrated that women who reported no prior mammogram (referent category, OR=1) have a 
higher likelihood of being diagnosed with breast cancer than those who reported having a prior 
mammogram (OR=.724, 95% CI=.539-.973) but are less likely than the unknown group 
(OR=1.328, 95% CI=.847-2.082). Using the lowest income and most represented group, 100% 
FPL as the referent group (OR=1), odds-ratio demonstrate the 150%FPL (OR=.906, 95% 
CI=.676-1.213) are less likely to be diagnosed with breast cancer while the 200% FPL 
(OR=1.243, 95% CI= .685-2.258) are 1.243 times more likely than those at the 100% FPL 
income level. Being Native Hawaiian/Pacific Islander (OR=5.369, 95% CI=1.116-25.831) 
increases the likelihood of being diagnosed with breast cancer compared to the White (OR=1) 
reference category. Though statistically significant, the large confidence interval indicates a low 
level of precision which is reasonable given the Native Hawaiian/Pacific Islander group are the 
most underrepresented racial group (n=17) making up less than .05% of the total sample. 
Speaking a language, other than English (OR=1) revealed mixed findings. Those in the 
Other/IndoEuropean (OR=1.858, 95% CI=.695-4.966) category and All others (OR=1.110, 95% 
CI=.312-3.950) were more likely to be diagnosed with breast cancer. Spanish (OR=.325, 95% 
CI=.154-.739) and Asian/Pacific Islander (OR=.352, 95% CI=.109-1.136) were less likely to be 
diagnosed with breast cancer compared to their English speaking counterparts, with Spanish 
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demonstrating statistical significance. When using the least educated (<9
th
 grade, OR=1) as the 
reference group, all other groups of participants , except those reporting “some college” 
(OR=.352, 95%CI=.109-1.136) were more likely to be diagnosed with breast cancer as follows: 
Some high school (OR=1.138, 95% CI=.689-1.881), High school graduate or equivalent 
(OR=1.120, 95% CI=.714-1.759), and Unknown (OR=1.110, 95% CI= .312-3.950). Among the 
35 Health districts, only four (Cumberland Plateau, Eastern Shore, Lenowisco and Mount 
Rogers) were significantly less likely to be diagnosed with breast cancer than those in the 
reference district, Fairfax. Appendix L provides the Omnibus Test of Model Coefficients, Model 
Summary, Hosmer and Lemeshow Test and Contingency Table, and Classification Table. 
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Table 4.3  RQ1 Breast cancer diagnosis (age continuous) 
            
   
Crude 95% C.I. Adjusted 95% C.I. 
       OR Lower Upper  OR Lower Upper 
         Race 
       
 
White 
       
 
Black 
 
1.064 0.939 1.206 0.826 0.640 1.065 
 
American Indian/Alaska 
Native 
 
0.978 0.432 2.215 0.600 0.081 4.441 
 
Asian 
 
0.570 0.392 0.830 0.843 0.373 1.902 
 
Pacific Islander/Native 
Hawaiian 
 
3.891 0.888 17.052 5.369 1.116 25.831 
 
Unknown 
 
0.658 0.473 0.916 1.051 0.566 1.952 
Age 
  
      
 
Continuous 
 
1.011 1.001 1.021 1.050 1.030 1.070 
Education 
 
      
 
<9th grade 
 
      
 
Some high school 
 
1.123 0.712 1.771 1.138 0.689 1.881 
 
High school graduate or 
equivalent 
 
1.092 0.731 1.630 1.120 0.714 1.759 
 
Some college or higher 
 
1.344 0.893 2.024 0.352 0.109 1.136 
 
Unknown 
 
1.899 1.042 3.459 1.110 0.312 3.950 
Income 
 
      
 
200% FPL 
 
0.789 0.498 1.251 1.243 0.685 2.258 
 
150% FPL 
 
1.095 0.927 1.294 0.906 0.676 0.121 
 
100% FPL 
 
      
Language 
 
      
 
English 
 
      
 
Spanish 
 
0.432 0.292 0.639 0.325 0.154 0.739 
 
Other/IndoEuropean 
 
1.238 0.633 2.419 1.858 0.695 4.966 
 
Asian/Pacific Islanders 
 
0.327 0.189 0.568 0.352 0.109 1.136 
 
Other 
 
1.519 0.775 2.979 1.110 0.312 3.950 
Prior mammo 
 
      
 
No 
 
      
 
Yes 
 
0.758 0.653 0.879 0.724 0.539 0.973 
  Unknown   1.046 0.786 1.393 1.328 0.847 2.082 
p=<.05 
       DV: Breast cancer (Yes=1, No=0) 
       note: referent group italicized font 
       note: Health districts included in model; output in Appendix M 
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 Recognizing that over 60% of the total sample did not report an educational level, it was 
important to compare the frequencies between those reporting an educational level and those not 
reporting an educational level. Chi-square tests results are presented in Table 4.4. The 
relationship between variables were significant with race X
2
(5, N=34,942)=59.367, age X
2
(1, 
N=34,492) =161.836, income X
2
(2, N=32,668)=108.037, language X
2
(4, N=34,885)=60.611 and 
prior mammogram X
2
(2, N=34,786)=83.005. When the frequencies were evaluated by 
enrollment site (n=52) only six had education consistently reported in 100% of cases. At the 
other end of the spectrum, 14 sites had zero cases (n=1,708) with education reported. 
Interestingly, none of those 14 sites are currently serving as enrollment sites for the program. A 
complete accounting of enrollment site compliance is provided in Appendix N. 
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Table 4.4 Chi-square test on education   
  
Education Level Reported No Education Level Reported 
 
  
n(% within total sample) n(% within total sample) Sig. 
     Race n=34,942 
  
<.001 
 
White 7155 (20.5%)  12526 (35.8%) 
 
 
Black 4309 (12.3%)    7513 (21.5%) 
 
 
American Indian 
/Alaska Native 
     51 (0.1%)       134 (0.4%) 
 
 
Asian    668 (1.9%)       845 (2.4%) 
 
 
Pacific 
Islander/Native 
Hawaiian 
     13 (0.0%)           4 (0.0%) 
 
 
Unknown    594 (1.7%)      1130 (3.2%) 
 
  
  
 Age n=34,492   <.001 
 
40-49 3811 (10.9%)    5230 (15.0%) 
 
 
50+ 8979 (25.7%)   16922 (48.4%) 
 
     Income n=32668    <.001 
 
200% FPL     380 (1.2%)      370 (1.1%) 
 
 
150% FPL     1993(6.1%)    2948 (9.0%) 
 
 
100% FPL 9574 (29.3%) 17403 (53.3%) 
 
  
  
 Language n=34,885   <.001 
 
English 11459 (32.8%) 20181 (57.9%) 
 
 
Spanish       649 (1.9%)     1074 (3.1%) 
 
 
Other/ 
IndoEuropean 
        80 (0.2%)      134 (0.4%) 
 
 
Asian/Pacific 
Islanders 
     534 (1.5%)     598 (1.7%) 
 
 
Other       53 (0.2%)     123 (0.4%) 
 
  
  
 
Prior 
mammo n=34,786   <.001 
 
No    1807 (5.2%)  3927 (11.3%) 
 
 
Yes 10286 (29.6%) 17292 (49.7%) 
   Unknown      607 (1.7%)      867 (2.5%)   
note: health districts and age (continuous) included in analysis; output in Appendix O 
  
The same regression models were conducted among women with no education level 
reported and the results are presented in Table 4.5. Between models with age as a continuous 
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variable, there were few differences noted with the exception of those speaking an Asian/Pacific 
Islander language (OR=.168, 95% CI=.054-.523) becoming statistically significant 85% less 
likely to be diagnosed with breast cancer compared to the English speaking reference group. 
Additionally, there were three different health districts (Chesterfield, Mount Rogers, 
Rappahannock) that now tested significantly less likely to be diagnosed than those in the Fairfax 
health district.  Though some variables changed statistically, none of the variables changed 
direction when compared to those women reporting educational levels. With age as a categorical 
variable between models, race no longer tested significant among women for whom no education 
was reported. Women having a prior mammogram (OR=.741, 95% CI=.612-.897) and those 
speaking a language other than English (Spanish OR=.476, 95% CI=.256-.883;Asian/Pacific 
Islander OR=.180, 95% CI=.054-.525) were less likely to be diagnosed compared to the referent 
group. Among women with no education reported, three health districts (Chesterfield, Mount 
Rogers, Prince William) were significantly less likely than those in Fairfax to be diagnosed with 
breast cancer whereas Cumberland Plateau, Eastern Shore, Lenowisco and Mount Rogers health 
districts had tested significant among those with education reported. Only the 40-49 year old age 
(OR=1.241, 95% CI=1.041-1.479) variable changed direction when compared to women with 
education reported, becoming 1.241 times more likely than the 50+ group to be diagnosed. A 
complete summary of statistical output for this analysis, with age as a categorical variable, is 
provided in Appendix P.  
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Table 4.5 RQ1-Breast Cancer diagnosis among women with no education reported (age continuous) 
         
    
95% C.I. 
 
95% C.I. 
N=20,165   
Crude 
OR 
Lower Upper Adjusted 
OR 
Lower Upper 
         Race 
        
 
White 
       
 
Black 
 
1.055 0.907 1.228 0.975 0.806 1.179 
 
American Indian/ 
Alaska Native 
 
0.830 0.305 2.254 0.732 0.231 2.324 
 
Asian/PI/NH 
 
0.551 0.338 0.899 1.136 0.593 2.176 
 
Unknown 
 
0.535 0.347 0.825 0.658 0.391 1.108 
Age 
        
 
Continuous 
 
0.992 0.981 1.004 0.992 0.980 1.004 
Income 
        
 
200% FPL 
 
0.565 0.266 1.200 0.611 0.287 1.301 
 
150% FPL 
 
1.201 0.980 1.472 0.120 0.974 1.487 
 
100% FPL 
       Language 
        
 
English 
       
 
Spanish 
 
0.373 0.223 0.624 0.473 0.255 0.878 
 
Other/ IndoEuropean 
 
1.020 0.416 2.499 1.165 0.453 2.999 
 
Asian/Pacific 
Islanders 
 
0.267 0.119 0.598 0.168 0.054 0.523 
 
Other 
 
1.588 0.738 3.416 1.329 0.508 3.481 
Prior mammo 
       
 
No 
       
 
Yes 
 
0.754 0.633 0.898 0.729 0.602 0.883 
  Unknown   0.760 0.509 1.135 0.715 0.459 1.113 
DV: breast cancer  (Yes=1, No=0) 
       note: referent group italicized font 
       note: Health districts included in model; output in Appendix Q 
    note: Pseudo R2:  Cox and Snell=.005; Naglekerke=.021 
    -2Log likelihood 5844.136, df=47 
        
Research question two (breast cancer stage) 
For the second research question, the same process was followed to build the logistic 
models with a change only in the dichotomous dependent variable, breast cancer stage (Stage 
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0/Invasive). A sub sample (n=1050), comprised of all women diagnosed with breast cancer, was 
available for analysis. With this reduced sample size, the race, language and health district 
categories were collapsed to provide sufficient power for analysis. Education was removed as an 
independent variable with severe underrepresentation (n=6) in the final analysis. A summary of 
the revised variable coding is presented in Table 4.6, along with the logistic regression results. 
Once again, a second regression model using age as a categorical variable was employed and 
those results are presented in Table 4.7. 
Among those diagnosed with breast cancer, logistic regression was employed to predict 
the probability that a participant would be diagnosed with invasive compared to Stage 0, non-
invasive breast cancer. Employing a .05 criterion of statistical significance, prior mammogram, 
income & geographic region had significant partial effects. Evaluating odds-ratios in the first 
model, for each one year increase in age (OR=1.001, 95% CI=.978-1.025) women 1.001 times 
more likely to be diagnosed with invasive breast cancer. The odds-ratio for race indicates that 
when holding all other variables constant, Black women (OR=1.151, 95% CI=.824-1.608) and 
other (OR=1.252, 95% CI= .559-2.805) women are 1.151 and 1.252 times more likely to be 
diagnosed with invasive breast cancer than the referent group (White, OR=1), respectively. 
Using the Central region as a reference category (OR=1), women residing in the Northwest 
(OR=2.138, 95% CI=1.149, 3.978), Southwest (OR=1.932, 95% CI= 1.275-2.926), and 
Southeast (OR=1.402, 95% CI=.976-2.013) regions demonstrate a higher likelihood of being 
diagnosed with invasive breast cancer. Women in the Northern region (OR=.933, 95% CI=.503-
1.729) are seven percent less likely than those in the Central region to be diagnosed with 
invasive breast cancer. Women speaking a language other than English (OR=.600, 95% CI=.248-
1.448) were 1.667 times less likely to be diagnosed with invasive breast cancer. The women in 
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the income reference category, 100% FPL (OR=1) are more likely than those in the 200% FPL 
(OR=.320, 95% CI=.126-.809) to have an invasive breast cancer diagnosis while the 150% FPL 
(OR=1.213, 95% CI=.813-1.811) are 1.213 times more likely than the reference group. In a 
second model, with age as a categorical variable, the 40-49 year old age group (OR=.968, 95% 
CI=.696-1.348) was found three percent less likely to be diagnosed with invasive breast cancer 
compared to the 50+ (OR=1) referent age group. With no significant change among the other 
independent variables, compared to the first model with age as a continuous variable, results are 
presented in Table 4.7 but not discussed separately.  Appendix R provides the Omnibus Test of 
Model Coefficients, Model Summary, Hosmer and Lemeshow Test and Contingency Table, and 
Classification Table for both models. 
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Table 4.6 
       RQ2 Breast cancer stage (age continuous)         
   
95% C.I. 
 
95% C.I. 
  
Crude 
OR 
Lower Upper Adjusted 
OR 
Lower Upper 
Age 
       
 
continuous .998 0.976 1.020 1.001 0.978 1.025 
Race 
       
 
White 
      
 
Black .972 0.730 1.293 1.151 0.824 1.608 
 
All others .680 0.405 1.140 1.252 0.559 2.805 
Language 
       
 
English 
      
 
Non-
English .552 0.317 0.962 0.600 0.248 1.448 
Health District 
      
 
Central 
      
 
*Northwest 2.437 1.339 4.438 2.138 1.149 3.978 
 
Northern .919 0.538 1.568 0.933 0.503 1.729 
 
*Southwest 2.004 1.366 2.939 1.932 1.275 2.926 
 
Southeast 1.522 1.092 2.121 1.402 0.976 2.013 
Income 
       
 
*200% FPL .298 0.120 0.743 0.320 0.126 0.809 
 
150% FPL 1.093 0.743 1.608 1.213 0.813 1.811 
 
100% FPL 
      Prior Mammogram 
      
 
No 
      
 
*Yes .495 0.336 0.728 0.448 0.295 0.681 
  *Unknown .451 0.235 0.868 0.426 0.212 0.858 
DV: Stage 0=0, Invasive=1 
     Note: Pseudo R2 Cox & Snell= .038; Nagelkerke= .056 
   -2Log likelihood 1143.453, df=12 
     *p<.05 
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Table 4.7 
       RQ2 Breast cancer stage (age continuous)       
   
95% C.I. 
 
95% C.I. 
  
Crude 
OR 
Lower Upper Adjusted 
OR 
Lower Upper 
Age 
       
 
40-49yo 1.020 0.751 1.386 0.968 0.696 1.348 
 
50+ 
      Race 
       
 
White 
      
 
Black .972 0.730 1.293 1.151 0.824 1.606 
 
All others .680 0.405 1.140 1.254 0.560 2.809 
Language 
       
 
English 
      
 
Non-
English .552 0.317 0.962 0.599 0.248 1.446 
Health District 
      
 
Central 
      
 
*Northwest 2.437 1.339 4.438 2.140 1.15 3.98 
 
Northern .919 0.538 1.568 0.934 0.504 1.731 
 
*Southwest 2.004 1.366 2.939 1.929 1.274 2.923 
 
Southeast 1.522 1.092 2.121 1.403 0.977 2.014 
Income 
       
 
*200% FPL .298 0.120 0.743 0.319 0.126 0.808 
 
150% FPL 1.093 0.743 1.608 1.214 0.814 1.812 
 
100% FPL 
     Prior Mammogram 
      
 
No 
      
 
*Yes .495 0.336 0.728 0.446 0.293 0.68 
  *Unknown .451 0.235 0.868 0.424 0.210 0.855 
DV: Stage 0=0, Invasive=1 
     Note: Pseudo R2 Cox & Snell= .038; Nagelkerke= .056 
   -2Log likelihood 1143.427, df=12 
    *p<.05 
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Research question three (source of information) 
For the third research question, while the focus shifts to sociodemographic determinants 
influencing the source of health information, the statistical procedures were largely the same. 
Binary logistic regression, with the dichotomous dependent variable, source of information 
(Provider/Non-provider) was executed and the results are presented. To clarify, in this study 
“provider” includes not only physicians but also nurses, health departments and clinics while 
“non-provider” may include community health workers, media sources, health fairs, family and 
friends. A sample (n=26,626) was used in the regression model analysis. Through univariate and 
chi-square analysis the independent variable, education, was not found to be significant and was 
excluded from the analysis. The iterative process of model-fitting the data, an improvement in 
the model’s ability to correct classify from 50% to 60% of the time was realized. 
Using a .05 level of statistical significance, all variables tested (age, income, geographic 
region, race and language) had significant partial effects. Those 40-49 (OR=.872, 95% CI= .823-
.924) were 13% less likely than those 50+ (OR=1) to report having heard about the EWL 
program from a provider. Interpreting the odds ratios reported in Table 4.8 for the regression 
model using the continuous age variable, age (OR=1.007, 95%CI=1.003-1.011) was found 
significant. That is, for every one year increase in age, participants were 1.007 times more likely 
to use a provider as their source of information for the EWL program. Using 100% FPL (OR=1) 
as the reference category, those in the 200% FPL (OR=1.535, 95% CI=1.284-1.834) group were 
found to be 1.5 times more likely to be referred by a provider. The 150% FPL (OR=.935, 95% 
CI=.871-1008) were only seven percent less likely than the lowest income group to have a 
provider refer them to the EWL program. Of the 34 health districts assessed against the referent, 
all were found to be up to 15 times more likely than the reference health district (Fairfax) to 
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report a provider referral with 32 of the 34 found to be statistically significant at the .05 criterion. 
Another statistically significant finding was those in the Black (OR=1.118, 95% CI= 1.049, 
1.191) race category were 1.118 times more likely than Whites (OR=1) to be referred by a health 
care provider.  American Indian/Alaska Native (OR=.778, 95% CI= .555-1.099) and Asian 
(OR=.885, 95% CI=.692-1.131) race categories were 12-22% less likely to be referred by a 
provider than the referent group while Pacific Islander/Native Hawaiian (OR=1.267, 95% 
CI=.430-3.731) and all Other (OR=1.022, 95% CI= .881-1.185) categories were more likely than 
Whites to be referred by a provider. Using those that speak English (OR=1) as the reference 
group, Spanish (OR=1.088, 95% CI= .926-1.277), Other/IndoEuropean (OR=1.019, 95% CI= 
.722-1.440) and All others (OR=1.114, 95% CI= .752-1.649) were found to be more likely to 
hear about the EWL program from a provider. Those who reported speaking an Asian/PI (OR= 
.540, 95% CI= .392-.744) language were found significantly less likely to be referred to the 
program by a provider. That is, this group is more likely to have non-provider serve as the source 
of referral. Appendix U provides the Omnibus Test of Model Coefficients, Model Summary, 
Hosmer and Lemeshow Test and Contingency Table, and Classification Table for both models. 
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Table 4.8 RQ3 Source of Information 
    N=26,626               
  
Crude 95% CI Adjusted 95% CI 
  
OR Lower Upper OR Lower Upper 
Age *continuous 1.005 1.001 1.008 1.007 1.003 1.011 
 
*40-49 .894 .848 .943 .872 .823 .924 
 
50+ 
      Race 
       
 
White 
      
 
*Black 1.096 1.043 1.152 1.118 1.049 1.191 
 
American Indian/ 
Alaska Native .778 .567 1.066 0.778 0.55 1.099 
 
Asian .265 .231 .303 .885 .692 1.131 
 
Pacific Islander/ 
Native Hawaiian 1.159 .420 3.198 1.267 .430 3.731 
 
Unknown .773 .692 .864 1.022 .881 1.185 
Language 
       
 
English 
      
 
Spanish .597 .535 .666 1.088 .926 1.277 
 
Other/ 
IndoEuropean .580 .430 .783 1.019 .722 1.440 
 
*Asian/ Pacific 
Islanders .165 .138 .196 .540 .392 .744 
 
Other .544 .389 .760 1.114 .752 1.649 
Income 
       
 
*200% FPL 1.492 1.264 1.762 1.535 1.284 1.834 
 
150% FPL .938 .878 1.003 0.935 0.871 1.008 
  100% FPL             
DV: Source of Information (Non-Provider=0, Provider=1) 
    Health districts included in analysis-output in Appendix S 
    Age (categorical) included in separate model-Appendix T 
    Note: Pseudo R2 Cox & Snell= .074; Nagelkerke= .099 
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CHAPTER 5 
DISCUSSION AND CONCLUSION 
 
This chapter presents a summary of results for each of the analyses described in Chapter 
4, a detailed discussion for each research question, limitations, implications for future practice 
and policy followed by study conclusions. 
 
Summary of results  
This section provides a synopsis of the results presented in the previous chapter. The analyses 
were designed to answer the following research questions about Virginia women utilizing the 
Every Woman’s Life program. 
RQ1.  What is the association between socio-demographic determinants (race, age, income, 
education, language and geographic location) and prior mammography and cancer diagnosis 
among women 40-64 years of age utilizing EWL services? 
RQ2. What is the association between socio-demographic determinants (race, age, income, 
education, language and geographic location) and prior mammography and cancer stage at 
the time of diagnosis among women 40-64 years of age utilizing EWL services? 
RQ3. What is the association between socio-demographic determinants (race, age, income, 
education, language and geographic location) and source of information among women 40-
64 years of age utilizing EWL services? 
 
The purpose of this study was to explore and identify factors that may impact participants’ 
breast cancer diagnoses, stage at the time of diagnosis and source of information to the Every 
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Woman’s Life program. Any findings, significant or otherwise, should be interpreted with 
caution and not generalized beyond Virginia women eligible for EWL breast cancer screening 
services. This research provided a unique opportunity to explore data not publicly available. 
A summary of findings is presented in Table 5.1.  Highlights of the statistically 
significant findings include: 
 The likelihood of being diagnosed with breast cancer increases with age 
for the subset of women who reported an educational level 
 Those with a prior mammogram were less likely to be diagnosed with 
breast cancer than those reporting no prior mammogram for the entire 
sample 
 Those with a prior mammogram were less likely to be diagnosed with 
invasive breast cancer than those reporting no prior mammogram 
 The “highest” income tier (200% FPL) were less likely to have invasive 
breast cancer than the “lowest” income tier (100% FPL) 
 The 200% FPL group were more likely to be referred to EWL by a 
provider than the 100% FPL group 
 The 40-49 age group were less likely than the 50+ to be diagnosed with 
breast cancer among those reporting education level; more likely among 
those not reporting an education level 
 Women reporting their race as “Black” were more likely to hear about the 
EWL program by a provider than their white counterparts 
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Table 5.1 
      Summary of study findings          
       
Variable 
 
Breast Cancer (RQ1) 
 
Breast Cancer Stage (RQ2) 
 
Source of 
information (RQ3) 
Age 
 
Sig. 
 
NS 
 
Sig. 
Race 
 
Sig. 
 
NS 
 
Sig. 
Education 
 
NS 
 
* 
 
* 
Language 
 
Sig. 
 
NS 
 
Sig. 
Income 
 
NS 
 
Sig. 
 
Sig. 
Geographic locale 
 
Sig. 
 
Sig. 
 
Sig. 
Prior mammogram   Sig.   Sig.   * 
       Sig.= statistically significant p<.05 
 NS = not significant 
  * = excluded from regression model 
     
Prior to discussing individual research questions, a review of the EWL database reveals a 
sample representative and reflective of the general population of Virginia, as provided by the US 
Census Bureau. The comparison is presented in Table 5.2. As expected in a sample of low 
income women, the highest education attained is lower (73.3%) compared to a statewide sample 
where 87.5% reported having graduated high school. Education is often used as an indicator of 
poverty as it is directly related to income and employment (Council on Virginia’s Future, 2015). 
Education was not found to be significant in any of the analyses in this study. However, the 
highest income group was found significantly less likely to be associated with an invasive breast 
cancer diagnosis compared to the lowest income group but more likely to be referred to the EWL 
program by a provider. 
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Table 5.2 
  Sample demographics compared to Virginia     
 
Percentage of 
Sample
a
 Virginia 
b
 
Race 
  White 56.30% 70.50% 
Black/African American 33.80% 19.70% 
American Indian/Alaska Native 0.50% 0.50% 
Asian 4.30% 6.30% 
Pacific Islander/Native Hawaiian <<0.1% 0.10% 
Other 4.90% 2.80% 
   Education 
  High school graduate or higher *73.3% 87.50% 
   Language 
  Language other than English spoken at home 9.30% 14.90% 
   a Sample N=34,942 
  * Available sample n=13,179 
  b Source U.S. Census Bureau: State and County QuickFacts, 2014 
  
Breast cancer diagnosis 
 Analysis for research question one focused on those factors predictive of a breast cancer 
diagnosis. In an effort to build the best model for the given data, univariate analysis was 
performed to assess the independent variables significantly associated with the dependent 
variable, breast cancer diagnosis. Further, correlations were calculated for all the independent 
variables to check for collinearity and aid in decision making around the model. The resultant 
model, using age as a continuous variable, indicated a high percentage (97%) of properly 
classifying each variable, indicating confidence in the fit of the model. Consistent with the 
literature, significant findings of logistic regression analysis included an increased likelihood of a 
breast cancer diagnosis with each one year increase in age. However, the younger 40-49 
(OR=1.241, 95% CI=1.041-1.479) were more likely to be diagnosed with breast cancer 
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compared to the 50+ reference group among those not reporting an educational level. Outside of 
the EWL targeted priority population, it is possible those 40-49 year old women receiving 
services reported a strong family history or symptoms when referred, though this information is 
not available and is only speculative. Those having reported a prior mammogram (OR= .724, 
95% CI=.539-.973) were found less likely to be diagnosed with breast cancer than those with no 
prior mammogram (OR=1) across the entire sample. With 17 cases in the sample, Native 
Hawaiian/Pacific Islander (OR=5.369, 95% CI= 1.116-25.831) were found significantly more 
likely to be diagnosed with breast cancer when compared to the White (OR=1) racial category. 
With this small sample, it is not unexpected to have a large confidence interval and the results 
should be interpreted carefully. Statistical resources (Field, 2009) promote caution with regard to 
the use and interpretation of R
2
 in logistic regression. However, the pseudo R
2
 measures, Cox & 
Snell and Naglekerke, provide at least a gauge of how well the model fits the data. The amount 
of variance in the outcome accounted for by the independent variables was .013, as measured by 
Cox & Snell pseudo R
2
. Other measures of model fit were observed throughout the process, 
including the -2LL (-2*log likelihood) which improved (decreased numerically) as independent 
variables were added to the model. 
 Within the framework of the socioecological model, mammograms are provided to the 
individual (intrapersonal level) by the EWL program (organizational level) and their coalition 
partners (community level) and funded through the NBCCEDP (policy level). Through an 
ecological perspective, there is focus on the system rather than the individual. In the case of the 
EWL, the system expands well beyond the individual though it requires individual action to 
acquire a screening mammogram. For instance, areas in the Commonwealth of Virginia with the 
highest incidence of breast cancer are available publicly and are presented in Figure 5.1 (NCI, 
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2015). Comparing the areas of highest incidence, denoted in red on the map in Figure 5.1, to the 
placement of EWL provider sites (Figure 5.2) it is observed that large geographic areas are 
served by a single enrollment site (organizational level).  It is only with the enlistment of 
community partners to provide clinical services (community level) that the need can be met. The 
results from this research add to the body of knowledge and inform EWL program officials with 
regard to determinants influential in breast cancer diagnosis, breast cancer stage and source of 
program information, using data spanning 15 years. 
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Breast cancer stage 
 Research question two focused on identifying factors which influence the stage at which 
breast cancer is detected and diagnosed. As discussed in Chapter 3, without complete staging 
information, an alternate staging stratification system was adopted for the analysis. Stage 0 
includes DCIS and LCIS (both considered non-invasive) while “invasive” is a broad term 
encompassing cancers that would be considered “early stage” (DCIS, Stage I, IA, IIB and IIIA) 
by the National Cancer Institute, along with more advanced staged cancers. Early stage is an 
important prognostic indicator for healthcare professionals when considering appropriate 
treatment for breast cancer and impacts long term survival (Soerjomataram et al., 2008). 
 Bivariate analysis was conducted to test significance associated with breast cancer stage. 
Education was not a significantly associated with the dependent variable. Additionally, education 
was a limiting variable due to missing cases within this smaller sample (n=1143) made up of 
only those diagnosed with breast cancer. For these reasons, education was excluded from the 
model in research question two. With the smaller sample for analysis other variables were 
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similarly evaluated and stratification levels were collapsed to assure adequate cases. The 35 
VDH health districts were collapsed into their respective five EWL regions (Central, Northwest, 
Northern, Southwest, Southeast). Both the race (White, Black/African American, Other) and 
language (English, Non-English) variables were adjusted at achieve required representation per 
cell. The percent of correct classification was moderately high (75%) indicating reasonable 
confidence in the model. The logistic regression demonstrated that preventive health behaviors, 
like mammograms, provide improved health outcomes as if often cited in the literature and is the 
essential message when promoting breast cancer screening programs (Gornick, Eggers & Riley, 
2004). In this sample, having a prior mammogram was found to be a protective factor for 
invasive breast cancer. That is, those with no prior mammogram (OR=1) were more likely to 
have an invasive cancer than those with a mammogram (OR=.448, 95% CI= .295-.681) or even 
those with an unknown screening history (OR=.426, 95% CI= .212-.858). With the Central 
region as a reference, both the NW (OR=2.138, 95% CI=1.149-3.978) and SW (OR= 1.932, 95% 
CI= 1.275-2.926) regions were significantly more likely to be diagnosed with invasive, rather 
than Stage 0. With these significant findings, a broad overview of the entire sample was explored 
by region (Appendix I). In general, participants in the NW and SW regions had less education, a 
higher percentage of women with no prior mammogram, a higher average age, a higher 
percentage in the White racial category and in the NW, a language other than English was 
spoken in 11% of the region. Also notable was that within the Northern region English was the 
language spoken everyday in less than 50% of those in the sample, with 23% Spanish and 
another 26% reporting an Asian language. Among the three income levels, the participants in the 
highest income 200% FPL group were almost 70% less likely to be diagnosed with invasive 
breast cancer than those in the lowest income bracket, 100% FPL. The results do provide 
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evidence to support the concept that incremental poverty produces incrementally poor health 
outcomes (Clegg et al., 2009; Sapolsky, 2005). Consistent with the literature that racial/ethnic 
minorities are more likely to have advanced stage cancer at the time of diagnosis, the regression 
analysis showed both Blacks/African American (OR=1.151, 95% CI=.824-1.608) and all other 
non-White (OR=1.252, 95% CI=.559-2.805) racial categories more likely to be diagnosed with 
invasive breast cancer compared to the White (OR=1) referent group (Henley, King, German, 
Richardson & Plescia, 2010). 
Source of information 
Research question three moves the emphasis from clinical outcome to source of health 
information about the EWL program. Provider recommendation saturates the health education 
literature as the most important factor in preventive health behaviors, like screening 
mammography (Schueler, 2008; Nuno, 2011; Young, 2011). Provider, which in this study may 
include physicians as well as family and friends, “sits” at the interpersonal level within the 
socioecological model. Non-provider sources of health information range from self (individual 
level), health departments (organizational level) and health fairs (community levels) and 
represent over 50% (51.2%, actual) of the responses in this sample. The regression analysis 
demonstrated the younger age group, 40-49 (OR=.872, 95% CI= .823-.924) were 13% less likely 
than 50+ category to hear about the EWL program from a provider. Likewise, those speaking 
Asian/Pacific Islander (OR= .540, 95% CI= .392-.744) languages were 1.85 times less likely 
than those speaking English to use providers as sources of health information, indicative that 
these women may prefer alternate sources of health information. The results for the tiered 
income levels (200% FPL, 150% FPL, 100% FPL) reinforce health indicators worsen with 
decreasing wealth, even among the lowest tiers of income (Chu, Miller & Springfield, 2007). In 
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the third research question, the logistic regression analysis found the highest income echelon 
(200% FPL) was 1.5 times more likely to hear about the EWL program from a provider 
compared to the 100% FPL group. 
Limitations 
The first limitation addresses the presence of bias. Aside from cancer staging 
information, demographic and health behavior information was self-reported by the participant 
using the Client Eligibility Form (Appendix E). Self-reported measures produce measurement 
error as other factors may influence the responses provided by the participant (Field, 2009). 
Within this sample, missing data (non-response bias) became problematic for the regression 
model with regard to education and smoking variables. Social desirability bias may be present 
with these variables as well.  
The second limitation addresses incomplete or missing data, in which the sample 
analyzed may not represent the full data set. AJCC and summary staging information, normally 
introduced into the EWL database when synchronized with the Virginia Cancer Registry 
database, was available for 40% (460/1143) of those diagnosed with breast cancer. This limited 
meaningful separation between “early” and “not early” stages of breast cancer in the sample, as 
was originally proposed for the study. Instead, separation was made on the basis of invasiveness. 
Ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) represent Stage 0 breast 
cancer or breast “condition” in the case of LCIS while all other cancers, were included in the 
invasive level. Within the invasive category there may exist cancers with a wide range of 
prognostic indicators, limiting the meaningful interpretation of the regression analysis. 
Additionally, the “unknown” status for race, education and mammogram presented some 
ambiguity as the researcher was unclear whether the “unknown” status was entered by the EWL 
 
 
96 
 
data entry personnel for cases in which the client eligibility form was left blank or if the 
participants actually entered “unknown” as a response. 
Third, as with much cancer research, the women studied may have unknown or 
undisclosed breast cancer risk factors which may have more influence than the variables 
presented in this study. These may include both non-modifiable factors, such as breast cancer 
family history, as well as life choices such as diet and exercise. 
A fourth limitation addresses the researcher’s decision to exclude a woman’s “intent to 
quit smoking” among smokers as a preventive health behavior due to missing data within the 
subset of women diagnosed with cancer. In retrospect, the participants’ non-smoking status 
would have been a more suitable proxy to serve as a preventive health behavior. 
Finally, the last limitation is the restricted generalizability of the study. These research 
results and interpretations must be confined to women who are eligible for EWL services. 
Implications for research/practice/policy  
To extend the socioecological model, areas for future research at the interpersonal level 
may include a more in-depth analysis of the sources of information for the EWL program 
commonly employed among low income women in Virginia, given that over 50% were referred 
by a source other than “provider” in this sample. 
Recommendations for the EWL program at the organizational level include a continued 
emphasis to recruit and promote screening mammography, especially among those with no 
screening history. Within the sample, 79% of participants reported a prior mammogram which 
surpasses statewide (78%) and national (75%) breast cancer screening rates (BRFSS, 2010). This 
study’s findings reinforce the premise that those with no prior mammogram are the most likely 
to be diagnosed with cancer and are more likely to be diagnosed with a more advanced stage of 
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cancer at the time of diagnosis. With over 55,000 duplicate cases removed from this analysis, 
representing women with more than one mammogram over the 15 year timeframe, program 
officials should continue to target those women with no history of a prior mammogram and those 
without a mammogram within the past two years.  
At the community level, EWL enrollment sites and coalition partners are recommended 
to have a heightened readiness to address linguistic, cultural and educational differences among 
the increasingly diverse communities served by the program. Appendices V and W provide 
demographic profiles for the sample stratified by health districts and EWL enrollment sites, 
respectively. To illustrate, the Alexandria health district with 144 women represented in the 
sample, has the lowest average income and lowest educational level attainment while the 
Virginia Beach health district (n=560) has the highest average education level. The Thomas 
Jefferson (n=1300) health district has the highest average income reported. The most racially and 
linguistically diverse health district is the Fairfax (n=1702) health district. Tailored health 
promotion messages designed at the health district level are appropriate. 
At a policy level, results of this study reinforce that health disparities persist across all 
socioeconomic levels, even among the poorest Virginians. Despite the passage of the Affordable 
Care Act (ACA) and its emphasis on preventive care and personalized medicine for all, low 
income women in Virginia will continue to need federally funded programs such as EWL since 
Virginia has not expanded Medicaid coverage to include low income adults (CMS, 2015). 
Additionally, there is no state legislation neither approved nor pending to require cultural 
competency training for state health professionals to assure compliance with National Cultural 
and Linguistically Appropriate Services in Health and Health Care (CLAS) standards (Office of 
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Minority Health, 2015). Advocacy efforts to support such legislation would strengthen and equip 
EWL’s network of clinical service providers to better serve its participants.  
Conclusions 
This research provided an investigation into factors influencing breast cancer screening, 
diagnosis, stage at the time of diagnosis and sources of health information in a sample of low 
income women 40-64 years of age. The results of the study confirmed long standing breast 
cancer risk factors, like the increasing incidence of breast cancer with increasing age and that 
those with a prior mammogram are diagnosed at earlier stages of breast cancer. Blacks/African 
American women were high utilizers of the program, comprising 33.8% of the sample while only 
representing 19.7% of the population in Virginia (US Census, 2014). This is in alignment with 
2014 CDC data indicating Black/African American women are screened at higher rates (73.2%) 
than other racial groups White (72.8%) American Indian/Alaska Native (68.2%), as presented in 
Figure 5.3. 
 
 
 
99 
 
 
This research aimed to provide a baseline of EWL-specific information for policymakers, 
program officials and practitioners alike. This research proves to be both timely and useful as 
breast cancer screening guidelines are once again in the media headlines, continuing the 
controversy regarding the appropriate age to begin mammographic screening. Within this 
relatively homogenous low-income sample of women, analyses show breast cancer and 
preventive health disparities persist. Specifically, the lowest income tier (100% FPL) was more 
likely to have invasive breast cancers diagnosed than the top tier (200% FPL). Again, those with 
the most relative “wealth” were more likely to use a health provider as the source of information 
about the EWL program. Finally, geographic regions in which demographic characteristics 
include women with less education, a lower percentage of prior mammograms and a language, 
other than English spoken in the house were more likely to be diagnosed with invasive breast 
cancer. Continued, regular evaluation of the program is recommended to accommodate new 
influences such as changes in population demographics or community partners as well as 
regional, state and federal policies that may impact EWL services. 
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Appendix K 
 
RQ1 Breast cancer diagnosis (age categorical)  
    
   
95% C.I. 
 
95% C.I. 
    
Crude 
OR Lower Upper 
Adjusted 
OR Lower Upper 
        Race 
       
 
White 
      
 
Black 1.064 0.939 1.206 0.816 0.633 1.052 
 
American Indian/ 
Alaska Native 0.978 0.432 2.215 0.592 0.080 4.379 
 
Asian 0.570 0.392 0.830 0.862 0.382 1.946 
 
Pacific Islander/ 
Native Hawaiian 3.891 0.888 17.052 5.339 1.117 25.530 
 
Unknown 0.658 0.473 0.916 1.021 0.551 1.893 
        Age 
       
 
40-49yo 1.001 0.875 1.145 0.750 0.585 0.962 
 
50+ 
      
        Education 
       
 
<9th grade 
      
 
Some high school 1.123 0.712 1.771 1.099 0.665 1.814 
 
High school 
graduate or 
equivalent 1.092 0.731 1.630 1.092 0.696 1.714 
 
Some college or 
higher 1.344 0.893 2.024 1.212 0.765 1.919 
 
Unknown 1.899 1.042 3.459 1.746 0.918 3.324 
        Income 
       
 
200% FPL 0.789 0.498 1.251 1.157 0.638 2.098 
 
150% FPL 1.095 0.927 1.294 0.922 0.689 1.235 
 
100% FPL 
      
        Language 
       
 
English 
      
 
Spanish 0.432 0.292 0.639 0.314 0.139 0.711 
 
Other/IndoEuropean 1.238 0.633 2.419 1.920 0.716 5.147 
 
Asian/Pacific 
Islanders 0.327 0.189 0.568 0.343 0.107 1.104 
 
Other 1.519 0.775 2.979 1.099 0.308 3.922 
        Prior mammo 
      
 
No 
      
 
Yes 0.758 0.653 0.879 0.764 0.570 1.024 
 Unknown 1.046 0.786 1.393 1.436 0.918 2.247 
note: referent group italicized font 
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Appendix L 
 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 Step 156.646 52 .000 
Block 156.646 52 .000 
Model 156.646 52 .000 
 
 
Model Summary 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 3135.399
a
 .013 .054 
a. Estimation terminated at iteration number 8 because 
parameter estimates changed by less than .001. 
 
 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 9.850 8 .276 
 
Contingency Table for Hosmer and Lemeshow Test 
 
CaStatus_All = No cancer 
diagnosed CaStatus_All = Cancer diagnosed 
Total Observed Expected Observed Expected 
Step 1 1 1192 1197.046 14 8.954 1206 
2 1192 1188.336 13 16.664 1205 
3 1188 1184.495 17 20.505 1205 
4 1174 1173.166 23 23.834 1197 
5 1183 1177.132 22 27.868 1205 
6 1174 1174.369 33 32.631 1207 
7 1171 1167.010 34 37.990 1205 
8 1147 1159.359 58 45.641 1205 
9 1144 1147.472 61 57.528 1205 
10 1112 1108.617 93 96.383 1205 
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Classification Table
a
 
 
Observed 
Predicted 
 
CaStatus_All 
Percentage 
Correct 
 
No cancer 
diagnosed 
Cancer 
diagnosed 
Step 1 CaStatus_All No cancer diagnosed 11677 0 100.0 
Cancer diagnosed 368 0 .0 
Overall Percentage   96.9 
a. The cut value is .500 
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Appendix M 
 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 HD_new_refFairfax   82.686 34 .000    
HD_new_refFairfax(1) -.756 .589 1.646 1 .199 .469 .148 1.490 
HD_new_refFairfax(2) .490 .818 .359 1 .549 1.632 .329 8.106 
HD_new_refFairfax(3) -.798 .441 3.270 1 .071 .450 .190 1.069 
HD_new_refFairfax(4) .149 .454 .108 1 .743 1.161 .477 2.828 
HD_new_refFairfax(5) -.641 .456 1.975 1 .160 .527 .216 1.288 
HD_new_refFairfax(6) -.379 .529 .514 1 .474 .685 .243 1.930 
HD_new_refFairfax(7) -.232 .591 .155 1 .694 .793 .249 2.523 
HD_new_refFairfax(8) -.722 1.081 .446 1 .504 .486 .058 4.045 
HD_new_refFairfax(9) -.997 .489 4.154 1 .042 .369 .141 .962 
HD_new_refFairfax(10) -1.107 .507 4.759 1 .029 .331 .122 .894 
HD_new_refFairfax(11) .216 .683 .100 1 .752 1.241 .325 4.739 
HD_new_refFairfax(12) -.160 .470 .116 1 .734 .852 .339 2.143 
HD_new_refFairfax(13) -.349 .486 .517 1 .472 .705 .272 1.828 
HD_new_refFairfax(14) -2.230 .694 10.339 1 .001 .107 .028 .419 
HD_new_refFairfax(15) -.797 .475 2.818 1 .093 .450 .178 1.143 
HD_new_refFairfax(16) .271 1.064 .065 1 .799 1.312 .163 10.559 
HD_new_refFairfax(17) -.938 .444 4.455 1 .035 .391 .164 .935 
HD_new_refFairfax(18) -1.084 .590 3.380 1 .066 .338 .107 1.074 
HD_new_refFairfax(19) -.475 .456 1.084 1 .298 .622 .254 1.520 
HD_new_refFairfax(20) -.021 .434 .002 1 .962 .980 .418 2.293 
HD_new_refFairfax(21) .484 .549 .776 1 .379 1.622 .553 4.757 
HD_new_refFairfax(22) .150 .472 .101 1 .751 1.162 .461 2.930 
HD_new_refFairfax(23) -.544 .539 1.018 1 .313 .580 .202 1.670 
HD_new_refFairfax(24) -.591 .658 .809 1 .369 .554 .153 2.009 
HD_new_refFairfax(25) -.664 .469 2.005 1 .157 .515 .205 1.291 
HD_new_refFairfax(26) .100 .509 .039 1 .844 1.105 .407 3.001 
HD_new_refFairfax(27) -.339 .476 .508 1 .476 .712 .280 1.810 
HD_new_refFairfax(28) -.292 .436 .448 1 .503 .747 .318 1.755 
HD_new_refFairfax(29) .201 .569 .125 1 .724 1.223 .401 3.734 
HD_new_refFairfax(30) -.601 .484 1.543 1 .214 .548 .213 1.415 
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HD_new_refFairfax(31) -.244 .510 .230 1 .632 .783 .288 2.128 
HD_new_refFairfax(32) .812 .446 3.307 1 .069 2.252 .939 5.402 
HD_new_refFairfax(33) .121 .465 .068 1 .794 1.129 .454 2.810 
HD_new_refFairfax(34) .087 .467 .035 1 .853 1.091 .437 2.722 
Age .049 .010 25.601 1 .000 1.050 1.030 1.070 
FPL   1.040 2 .595    
FPL(1) .218 .304 .512 1 .474 1.243 .685 2.258 
FPL(2) -.099 .149 .440 1 .507 .906 .676 1.213 
PHB2_mammo   12.649 2 .002    
PHB2_mammo(1) -.323 .150 4.599 1 .032 .724 .539 .973 
PHB2_mammo(2) .283 .230 1.525 1 .217 1.328 .847 2.082 
Race   7.382 5 .194    
Race(1) -.192 .130 2.170 1 .141 .826 .640 1.065 
Race(2) -.511 1.022 .251 1 .617 .600 .081 4.441 
Race(3) -.171 .415 .170 1 .680 .843 .373 1.902 
Race(4) 1.681 .801 4.398 1 .036 5.369 1.116 25.831 
Race(5) .050 .316 .025 1 .874 1.051 .566 1.952 
Language   13.151 4 .011    
Language(1) -1.125 .420 7.189 1 .007 .325 .143 .739 
Language(2) .620 .502 1.526 1 .217 1.858 .695 4.966 
Language(3) -1.045 .598 3.052 1 .081 .352 .109 1.136 
Language(4) .104 .648 .026 1 .872 1.110 .312 3.950 
Education   3.841 4 .428    
Education(1) .129 .256 .255 1 .613 1.138 .689 1.881 
Education(2) .114 .230 .244 1 .621 1.120 .714 1.759 
Education(3) .217 .235 .855 1 .355 1.243 .784 1.969 
Education(4) .564 .329 2.942 1 .086 1.757 .923 3.347 
Constant -5.387 .687 61.571 1 .000 .005   
a. Variable(s) entered on step 1: HD_new_refFairfax, Age, FPL, PHB2_mammo, Race, Language, Education. 
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Appendix O 
 
    Education Level Reported No Education Level Reported   
    n(% within total sample) n(% within total sample) Sig. 
          
Age n=34,942     <.001 
  40 247 (0.7%) 418 (1.2%)   
  41 243 (0.7%) 408 (1.2%   
  42 263 (0.8%) 414 (1.2%)   
  43 284 (0.8%) 428 (1.2%)   
  44 332 (1.0%) 450 (1.3%)   
  45 399 (1.1%) 668 (1.9%)   
  46 450 (1.3%) 596 (1.7%)   
  47 475 (1.4%) 562 (1.7%)   
  48 511 (1.5%) 603 (1.7%)   
  49 607 (1.7%) 683 (2.0%)   
  50 1366 (3.9%) 1967 (5.6%)   
  51 1104 (3.2%) 1509 (4.3%)   
  52 913 (2.6%) 1354 (3.9%)   
  53 813 (2.3%) 1291 (3.7%)   
  54 717 (2.1%) 1226 (3.5%)   
  55 654 (1.9%) 1122 (3.2%)   
  56 579 (1.7%) 1051 (3.0%)   
  57 512 (1.5%) 1032 (3.0%)   
  58 494 (1.4%) 981 (2.8%)   
  59 431 (1.2%) 961 (2.8%)   
  60 364 (1.0%) 887 (2.5%)   
  61 327 (0.9%) 940 (2.7%)   
  62 297 (0.8%) 952 (2.7%)   
  63 227 (0.6%) 952 (2.7%)   
  64 181 (0.5%) 697 (2.0%)   
Health 
Districts n=34,270     <.001 
  Alexandria 86 (0.3%) 58 (0.2%)   
  Alleghany 213 (0.6%) 334 (1.0%)   
  Arlington 30 (0.1%) 129 (0.4%)   
  
Central 
Shenandoah 856 (0.1%) 1040 (3.0%)   
  Central Virginia 299 (0.9%) 667 (1.9%)   
  Chesapeake 631 (1.8%) 1161 (3.4%)   
 
 
135 
 
  Chesterfield 222 (0.6%) 589 (1.7%)   
  Chickahominy 132 (0.4%) 184 (0.5%)   
  Crater 40 (0.1%) 135 (0.4%)   
  
Cumberland 
Plateau 652 (1.7%) 1050 (3.1%)   
  Eastern Shore 576 (1.7%) 569 (1.7%)   
  Fairfax 676 (2.0%) 1026 (3.0%)   
  Hampton 380 (1.1%) 831 (2.4%)   
  Henrico 331 (1.0%) 314 (0.9%)   
  Lenowisco  560 (1.6%) 974 (2.8%)   
  Lord Fairfax 565 (1.6%) 916 (2.7%)   
  Loudoun 34 (0.1%) 196 (0.6%)   
  Mount Rogers 988 (2.9%) 1288 (3.8%)   
  New River 265 (0.8%) 475 (1.4%)   
  Norfolk 689 (2.0%) 1321 (3.9%)   
  Peninsula 512 (1.5%) 1168 (3.4%)   
  Piedmont 92 (0.3%) 114 (0.3%)   
  
Pittsylvania-
Danville 217 (0.6%) 528 (1.5%)   
  Portsmouth 320 (0.9%) 650 (1.9%)   
  Prince William 202 (0.6%) 192 (0.6%)   
  Rappahannock 490 (1.4%) 865 (2.5%)   
  
Rappahannock 
Rapidan 174 (0.5%) 377 (1.1%)   
  Richmond 364 (1.1%) 817 (2.4%)   
  Roanoke 364 (1.1%) 817 (2.4%)   
  Southside 103 (0.3%) 135 (0.4%)   
  Thomas Jefferson 445 (1.3%) 855 (2.5%)   
  Three Rivers 241 (0.7%) 496 (1.4%)   
  Virginia Beach 179 (0.5%) 381 (1.1%)   
  West Piedmont 240 (0.7%) 504 (1.5%)   
  Western Tidewater 292 (0.9%) 428 (1.2%)   
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Appendix P 
 
 
RQ1 Odds Ratio for those without education status (age categorical) 
  
    
95% C.I. 
 
95% C.I. 
      
Crude 
OR Lower Upper 
Adjusted 
OR Lower Upper 
         Race 
        
 
White 
       
 
Black 
 
1.055 0.907 1.228 0.978 0.809 1.183 
 
American Indian/ Alaska 
Native 
 
0.830 0.305 2.254 0.739 0.233 2.346 
 
Asian/PI/NH 
 
0.551 0.338 0.899 1.146 0.598 2.196 
 
Unknown 
 
0.535 0.347 0.825 0.658 0.391 1.107 
Age 
        
 
40-49 
 
1.205 1.025 1.417 1.241 1.041 1.479 
 
50+ 
       Income 
        
 
200% FPL 
 
0.565 0.266 1.200 0.619 0.291 1.317 
 
150% FPL 
 
1.201 0.980 1.472 1.207 0.977 1.492 
 
100% FPL 
       Language 
        
 
English 
       
 
Spanish 
 
0.373 0.223 0.624 0.476 0.256 0.883 
 
Other/IndoEuropean 
 
1.020 0.416 2.499 1.171 0.455 3.015 
 
Asian/Pacific Islanders 
 
0.267 0.119 0.598 0.180 0.054 0.525 
 
Other 
 
1.588 0.738 3.416 1.325 0.506 3.469 
Prior mammo 
       
 
No 
       
 
Yes 
 
0.754 0.633 0.898 0.741 0.612 0.897 
  Unknown   0.760 0.509 1.135 0.721 0.463 1.123 
note: referent group italicized font 
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Appendix Q 
RQ1-Crude Odds Ratio 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 HD_new_refFairfax   60.850 34 .003    
HD_new_refFairfax(1) .882 .311 8.031 1 .005 2.415 1.312 4.444 
HD_new_refFairfax(2) -.461 .741 .387 1 .534 .631 .148 2.694 
HD_new_refFairfax(3) .390 .263 2.204 1 .138 1.477 .883 2.472 
HD_new_refFairfax(4) .562 .280 4.037 1 .045 1.754 1.014 3.036 
HD_new_refFairfax(5) .432 .255 2.862 1 .091 1.540 .934 2.540 
HD_new_refFairfax(6) -.272 .366 .553 1 .457 .762 .372 1.560 
HD_new_refFairfax(7) .300 .462 .422 1 .516 1.350 .546 3.337 
HD_new_refFairfax(8) -17.513 3459.260 .000 1 .996 .000 .000 . 
HD_new_refFairfax(9) .512 .257 3.981 1 .046 1.668 1.009 2.758 
HD_new_refFairfax(10) .269 .314 .733 1 .392 1.308 .707 2.419 
HD_new_refFairfax(11) .781 .627 1.555 1 .212 2.184 .640 7.457 
HD_new_refFairfax(12) .472 .271 3.034 1 .082 1.604 .943 2.728 
HD_new_refFairfax(13) .625 .340 3.376 1 .066 1.869 .959 3.640 
HD_new_refFairfax(14) .206 .277 .554 1 .457 1.229 .714 2.113 
HD_new_refFairfax(15) .074 .289 .066 1 .797 1.077 .611 1.900 
HD_new_refFairfax(16) -.885 .739 1.434 1 .231 .413 .097 1.757 
HD_new_refFairfax(17) -.013 .272 .002 1 .963 .987 .579 1.683 
HD_new_refFairfax(18) .565 .305 3.429 1 .064 1.760 .968 3.202 
HD_new_refFairfax(19) .345 .253 1.860 1 .173 1.412 .860 2.318 
HD_new_refFairfax(20) .376 .257 2.135 1 .144 1.457 .879 2.413 
HD_new_refFairfax(21) 1.106 .419 6.971 1 .008 3.022 1.330 6.868 
HD_new_refFairfax(22) .982 .271 13.147 1 .000 2.669 1.570 4.538 
HD_new_refFairfax(23) .589 .280 4.432 1 .035 1.802 1.041 3.119 
HD_new_refFairfax(24) -.453 .616 .541 1 .462 .636 .190 2.126 
HD_new_refFairfax(25) -.161 .313 .267 1 .606 .851 .461 1.570 
HD_new_refFairfax(26) .506 .332 2.321 1 .128 1.659 .865 3.182 
HD_new_refFairfax(27) .351 .279 1.583 1 .208 1.421 .822 2.456 
HD_new_refFairfax(28) .689 .257 7.202 1 .007 1.993 1.204 3.297 
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HD_new_refFairfax(29) .201 .546 .135 1 .713 1.223 .419 3.568 
HD_new_refFairfax(30) .410 .273 2.254 1 .133 1.506 .882 2.572 
HD_new_refFairfax(31) .467 .309 2.276 1 .131 1.595 .870 2.925 
HD_new_refFairfax(32) .495 .332 2.222 1 .136 1.641 .856 3.147 
HD_new_refFairfax(33) .818 .283 8.354 1 .004 2.266 1.301 3.947 
HD_new_refFairfax(34) .374 .332 1.274 1 .259 1.454 .759 2.786 
Constant -3.690 .202 332.086 1 .000 .025   
a. Variable(s) entered on step 1: HD_new_refFairfax. 
 
RQ1-Fully adjusted  
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 Age -.008 .006 1.679 1 .195 .992 .980 1.004 
FPL   4.820 2 .090    
FPL(1) -.493 .386 1.633 1 .201 .611 .287 1.301 
FPL(2) .185 .108 2.944 1 .086 1.204 .974 1.487 
PHB2_mammo   10.593 2 .005    
PHB2_mammo(1) -.316 .098 10.415 1 .001 .729 .602 .883 
PHB2_mammo(2) -.336 .226 2.209 1 .137 .715 .459 1.113 
Language   16.531 4 .002    
Language(1) -.749 .316 5.634 1 .018 .473 .255 .878 
Language(2) .153 .482 .101 1 .751 1.165 .453 2.999 
Language(3) -1.785 .581 9.456 1 .002 .168 .054 .523 
Language(4) .285 .491 .335 1 .562 1.329 .508 3.481 
HD_new_refFairfax   45.845 34 .084    
HD_new_refFairfax(1) .175 .362 .233 1 .629 1.191 .586 2.420 
HD_new_refFairfax(2) -.436 .754 .335 1 .563 .646 .147 2.834 
HD_new_refFairfax(3) -.165 .306 .291 1 .590 .848 .466 1.544 
HD_new_refFairfax(4) -.089 .323 .076 1 .783 .915 .485 1.724 
HD_new_refFairfax(5) -.197 .302 .423 1 .515 .821 .454 1.486 
HD_new_refFairfax(6) -.812 .402 4.085 1 .043 .444 .202 .976 
HD_new_refFairfax(7) -.433 .521 .693 1 .405 .648 .234 1.799 
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HD_new_refFairfax(8) -18.088 3629.400 .000 1 .996 .000 .000 . 
HD_new_refFairfax(9) -.128 .304 .177 1 .674 .880 .485 1.597 
HD_new_refFairfax(10) -.451 .366 1.522 1 .217 .637 .311 1.304 
HD_new_refFairfax(11) .218 .761 .082 1 .775 1.243 .280 5.525 
HD_new_refFairfax(12) -.073 .314 .054 1 .816 .930 .502 1.722 
HD_new_refFairfax(13) .013 .395 .001 1 .975 1.013 .467 2.198 
HD_new_refFairfax(14) -.496 .325 2.321 1 .128 .609 .322 1.153 
HD_new_refFairfax(15) -.597 .337 3.144 1 .076 .550 .284 1.065 
HD_new_refFairfax(16) -1.218 .748 2.654 1 .103 .296 .068 1.281 
HD_new_refFairfax(17) -.649 .320 4.101 1 .043 .523 .279 .979 
HD_new_refFairfax(18) -.243 .367 .440 1 .507 .784 .382 1.609 
HD_new_refFairfax(19) -.262 .301 .757 1 .384 .770 .427 1.388 
HD_new_refFairfax(20) -.235 .303 .602 1 .438 .790 .436 1.432 
HD_new_refFairfax(21) .509 .447 1.294 1 .255 1.663 .692 3.996 
HD_new_refFairfax(22) .288 .319 .814 1 .367 1.334 .713 2.494 
HD_new_refFairfax(23) -.193 .337 .330 1 .566 .824 .426 1.594 
HD_new_refFairfax(24) -.576 .626 .847 1 .357 .562 .165 1.917 
HD_new_refFairfax(25) -.819 .361 5.129 1 .024 .441 .217 .896 
HD_new_refFairfax(26) -.043 .366 .014 1 .906 .958 .467 1.962 
HD_new_refFairfax(27) -.271 .325 .695 1 .404 .762 .403 1.443 
HD_new_refFairfax(28) .049 .303 .027 1 .870 1.051 .580 1.905 
HD_new_refFairfax(29) -.365 .569 .412 1 .521 .694 .228 2.116 
HD_new_refFairfax(30) -.208 .314 .437 1 .509 .812 .439 1.504 
HD_new_refFairfax(31) -.386 .372 1.074 1 .300 .680 .328 1.410 
HD_new_refFairfax(32) -.147 .378 .151 1 .698 .863 .412 1.811 
HD_new_refFairfax(33) .202 .328 .381 1 .537 1.224 .644 2.326 
HD_new_refFairfax(34) -.129 .368 .122 1 .727 .879 .428 1.808 
Race_5levels   3.019 4 .555    
Race_5levels(1) -.025 .097 .068 1 .795 .975 .806 1.179 
Race_5levels(2) -.312 .589 .280 1 .597 .732 .231 2.324 
Race_5levels(3) .127 .332 .148 1 .701 1.136 .593 2.176 
Race_5levels(4) -.418 .266 2.477 1 .116 .658 .391 1.108 
Constant -2.376 .420 32.053 1 .000 .093   
a. Variable(s) entered on step 1: Age, FPL, PHB2_mammo, Language, HD_new_refFairfax, Race_5levels. 
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Appendix R 
RQ2-Age continuous model 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 Step 40.735 12 .000 
Block 40.735 12 .000 
Model 40.735 12 .000 
 
Model Summary 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 1143.453
a
 .038 .056 
a. Estimation terminated at iteration number 4 because 
parameter estimates changed by less than .001. 
 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 2.436 8 .965 
 
Contingency Table for Hosmer and Lemeshow Test 
 
EWLstage_binary = Stage 0 EWLstage_binary = Invasive 
Total Observed Expected Observed Expected 
Step 1 1 43 42.474 61 61.526 104 
2 35 35.269 69 68.731 104 
3 32 32.594 73 72.406 105 
4 31 28.456 73 75.544 104 
5 25 25.520 76 75.480 101 
6 24 25.061 81 79.939 105 
7 18 22.979 87 82.021 105 
8 22 20.840 83 84.160 105 
9 21 18.128 85 87.872 106 
10 13 12.679 98 98.321 111 
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Classification Table
a
 
 
Observed 
Predicted 
 
EWLstage_binary Percentage 
Correct 
 
Stage 0 Invasive 
Step 1 EWLstage_binary Stage 0 8 256 3.0 
Invasive 4 782 99.5 
Overall Percentage   75.2 
a. The cut value is .500 
 
 
RQ2-Age categorical model 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 Step 40.761 12 .000 
Block 40.761 12 .000 
Model 40.761 12 .000 
 
Model Summary 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 1143.427
a
 .038 .056 
a. Estimation terminated at iteration number 4 because 
parameter estimates changed by less than .001. 
 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 4.757 8 .783 
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Contingency Table for Hosmer and Lemeshow Test 
 
EWLstage_binary = Stage 0 EWLstage_binary = Invasive 
Total Observed Expected Observed Expected 
Step 1 1 38 36.532 49 50.468 87 
2 33 36.118 72 68.882 105 
3 34 33.055 71 71.945 105 
4 32 28.737 71 74.263 103 
5 40 40.126 119 118.874 159 
6 11 14.213 50 46.787 61 
7 20 23.153 86 82.847 106 
8 18 20.141 83 80.859 101 
9 23 17.786 79 84.214 102 
10 15 14.137 106 106.863 121 
 
 
Classification Table
a
 
 
Observed 
Predicted 
 
EWLstage_binary Percentage 
Correct 
 
Stage 0 Invasive 
Step 1 EWLstage_binary Stage 0 8 256 3.0 
Invasive 4 782 99.5 
Overall Percentage   75.2 
a. The cut value is .500 
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Appendix S 
RQ3-Health district output 
 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 FPL   26.845 2 .000    
FPL(1) .428 .091 22.104 1 .000 1.535 1.284 1.834 
FPL(2) -.068 .036 3.481 1 .062 .935 .871 1.003 
Age .007 .002 10.290 1 .001 1.007 1.003 1.011 
HD   1246.755 34 .000    
HD(1) 1.548 .282 30.184 1 .000 4.701 2.706 8.165 
HD(2) .503 .347 2.103 1 .147 1.654 .838 3.266 
HD(3) 1.446 .269 28.815 1 .000 4.248 2.505 7.203 
HD(4) 2.248 .274 67.462 1 .000 9.464 5.536 16.181 
HD(5) 2.410 .270 79.861 1 .000 11.130 6.561 18.881 
HD(6) 2.221 .276 64.879 1 .000 9.214 5.367 15.816 
HD(7) 2.494 .294 71.796 1 .000 12.109 6.801 21.560 
HD(8) 2.751 .326 71.337 1 .000 15.658 8.270 29.646 
HD(9) 2.073 .270 58.721 1 .000 7.947 4.677 13.504 
HD(10) 1.117 .273 16.723 1 .000 3.054 1.789 5.216 
HD(11) .448 .275 2.653 1 .103 1.565 .913 2.682 
HD(12) 2.368 .272 75.547 1 .000 10.677 6.259 18.212 
HD(13) 2.486 .280 78.684 1 .000 12.015 6.937 20.810 
HD(14) 1.954 .271 51.962 1 .000 7.059 4.149 12.009 
HD(15) 2.335 .271 74.485 1 .000 10.331 6.079 17.558 
HD(16) 1.426 .303 22.089 1 .000 4.162 2.296 7.543 
HD(17) 2.540 .269 88.935 1 .000 12.678 7.478 21.494 
HD(18) 1.404 .279 25.257 1 .000 4.073 2.355 7.043 
HD(19) 1.879 .269 48.625 1 .000 6.548 3.861 11.104 
HD(20) 1.939 .270 51.658 1 .000 6.952 4.097 11.797 
HD(21) 1.895 .306 38.263 1 .000 6.654 3.650 12.131 
HD(22) 1.868 .276 45.750 1 .000 6.477 3.769 11.130 
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HD(23) 1.785 .275 42.218 1 .000 5.960 3.479 10.213 
HD(24) .795 .292 7.388 1 .007 2.214 1.248 3.926 
HD(25) 1.918 .271 50.162 1 .000 6.807 4.004 11.574 
HD(26) 2.538 .282 80.843 1 .000 12.658 7.279 22.013 
HD(27) 2.235 .273 67.244 1 .000 9.347 5.478 15.946 
HD(28) 1.883 .271 48.402 1 .000 6.573 3.867 11.172 
HD(29) 1.418 .304 21.778 1 .000 4.129 2.276 7.491 
HD(30) 2.095 .271 59.601 1 .000 8.125 4.774 13.831 
HD(31) 1.322 .277 22.715 1 .000 3.749 2.177 6.456 
HD(32) 1.411 .282 24.967 1 .000 4.099 2.357 7.128 
HD(33) 1.483 .277 28.593 1 .000 4.407 2.559 7.591 
HD(34) 1.646 .278 35.159 1 .000 5.185 3.009 8.932 
Race   16.503 5 .006    
Race(1) .111 .033 11.698 1 .001 1.118 1.049 1.191 
Race(2) -.251 .177 2.026 1 .155 .778 .550 1.099 
Race(3) -.123 .125 .956 1 .328 .885 .692 1.131 
Race(4) .237 .551 .184 1 .668 1.267 .430 3.731 
Race(5) .021 .076 .080 1 .777 1.022 .881 1.185 
Language   18.313 4 .001    
Language(1) .084 .082 1.046 1 .306 1.088 .926 1.277 
Language(2) .019 .176 .012 1 .913 1.019 .722 1.440 
Language(3) -.616 .163 14.209 1 .000 .540 .392 .744 
Language(4) .108 .200 .290 1 .590 1.114 .752 1.649 
Constant -2.302 .287 64.133 1 .000 .100   
a. Variable(s) entered on step 1: FPL, Age, HD, Race, Language. 
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Appendix T 
RQ3 Age categorical model 
 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 FPL   26.066 2 .000    
FPL(1) .420 .091 21.302 1 .000 1.522 1.274 1.820 
FPL(2) -.068 .036 3.507 1 .061 .934 .870 1.003 
HD   1246.532 34 .000    
HD(1) 1.544 .282 30.042 1 .000 4.684 2.697 8.137 
HD(2) .499 .347 2.070 1 .150 1.648 .834 3.253 
HD(3) 1.444 .269 28.696 1 .000 4.235 2.498 7.183 
HD(4) 2.250 .274 67.589 1 .000 9.487 5.549 16.221 
HD(5) 2.413 .270 80.050 1 .000 11.165 6.581 18.941 
HD(6) 2.219 .276 64.768 1 .000 9.198 5.358 15.791 
HD(7) 2.495 .294 71.821 1 .000 12.117 6.805 21.575 
HD(8) 2.749 .326 71.232 1 .000 15.631 8.255 29.598 
HD(9) 2.069 .271 58.471 1 .000 7.914 4.657 13.448 
HD(10) 1.116 .273 16.701 1 .000 3.053 1.787 5.213 
HD(11) .447 .275 2.648 1 .104 1.564 .913 2.681 
HD(12) 2.361 .272 75.094 1 .000 10.605 6.217 18.090 
HD(13) 2.482 .280 78.398 1 .000 11.964 6.907 20.724 
HD(14) 1.958 .271 52.169 1 .000 7.088 4.166 12.059 
HD(15) 2.331 .271 74.207 1 .000 10.289 6.054 17.487 
HD(16) 1.427 .303 22.112 1 .000 4.165 2.298 7.550 
HD(17) 2.536 .269 88.637 1 .000 12.628 7.448 21.409 
HD(18) 1.401 .279 25.135 1 .000 4.060 2.347 7.020 
HD(19) 1.883 .270 48.798 1 .000 6.571 3.875 11.145 
HD(20) 1.937 .270 51.559 1 .000 6.941 4.090 11.778 
HD(21) 1.905 .306 38.634 1 .000 6.718 3.684 12.248 
HD(22) 1.863 .276 45.478 1 .000 6.443 3.749 11.071 
HD(23) 1.786 .275 42.249 1 .000 5.966 3.482 10.222 
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HD(24) .795 .292 7.399 1 .007 2.215 1.249 3.928 
HD(25) 1.915 .271 50.010 1 .000 6.789 3.993 11.543 
HD(26) 2.544 .282 81.180 1 .000 12.730 7.319 22.138 
HD(27) 2.237 .273 67.335 1 .000 9.364 5.488 15.976 
HD(28) 1.879 .271 48.200 1 .000 6.549 3.852 11.132 
HD(29) 1.414 .304 21.634 1 .000 4.110 2.266 7.457 
HD(30) 2.105 .271 60.173 1 .000 8.211 4.823 13.977 
HD(31) 1.321 .277 22.683 1 .000 3.746 2.175 6.452 
HD(32) 1.412 .282 24.990 1 .000 4.102 2.359 7.134 
HD(33) 1.484 .277 28.616 1 .000 4.411 2.561 7.597 
HD(34) 1.645 .278 35.128 1 .000 5.182 3.008 8.928 
Race   16.239 5 .006    
Race(1) .110 .033 11.384 1 .001 1.116 1.047 1.190 
Race(2) -.255 .177 2.084 1 .149 .775 .548 1.095 
Race(3) -.122 .125 .948 1 .330 .885 .692 1.132 
Race(4) .249 .551 .204 1 .651 1.283 .436 3.777 
Race(5) .022 .076 .082 1 .774 1.022 .881 1.186 
Language   18.452 4 .001    
Language(1) .082 .082 1.005 1 .316 1.086 .924 1.275 
Language(2) .022 .176 .016 1 .899 1.023 .724 1.445 
Language(3) -.619 .163 14.338 1 .000 .539 .391 .742 
Language(4) .110 .200 .303 1 .582 1.117 .754 1.653 
Age_binary(1) -.137 .030 21.465 1 .000 .872 .823 .924 
Constant -1.904 .265 51.675 1 .000 .149   
a. Variable(s) entered on step 1: FPL, HD, Race, Language, Age_binary. 
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Appendix U 
RQ3 Age continuous model 
 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 Step 2061.161 46 .000 
Block 2061.161 46 .000 
Model 2061.161 46 .000 
 
Model Summary 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 34840.544
a
 .074 .099 
a. Estimation terminated at iteration number 5 because 
parameter estimates changed by less than .001. 
 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 9.342 8 .314 
 
Contingency Table for Hosmer and Lemeshow Test 
 
EWL_referral = Non-provider EWL_referral = Provider 
Total Observed Expected Observed Expected 
Step 1 1 2118 2131.289 533 519.711 2651 
2 1736 1693.426 913 955.574 2649 
3 1532 1576.380 1126 1081.620 2658 
4 1367 1376.993 1281 1271.007 2648 
5 1349 1321.386 1302 1329.614 2651 
6 1280 1273.060 1371 1377.940 2651 
7 1209 1199.228 1458 1467.772 2667 
8 1051 1078.898 1623 1595.102 2674 
9 990 980.337 1641 1650.663 2631 
10 936 937.001 1810 1808.999 2746 
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Classification Table
a
 
 
Observed 
Predicted 
 
EWL_referral Percentage 
Correct 
 
Non-provider Provider 
Step 1 EWL_referral Non-provider 7316 6252 53.9 
Provider 4364 8694 66.6 
Overall Percentage   60.1 
a. The cut value is .500 
 
 
RQ3 Age categorical model 
 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 Step 2072.349 46 .000 
Block 2072.349 46 .000 
Model 2072.349 46 .000 
 
 
Model Summary 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 34829.355
a
 .075 .100 
a. Estimation terminated at iteration number 5 because 
parameter estimates changed by less than .001. 
 
 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 3.924 8 .864 
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Contingency Table for Hosmer and Lemeshow Test 
 
EWL_referral = Non-provider EWL_referral = Provider 
Total Observed Expected Observed Expected 
Step 1 1 2126 2142.113 539 522.887 2665 
2 1706 1686.192 931 950.808 2637 
3 1547 1566.350 1094 1074.650 2641 
4 1341 1330.043 1199 1209.957 2540 
5 1310 1308.243 1309 1310.757 2619 
6 1319 1292.363 1376 1402.637 2695 
7 1206 1213.334 1485 1477.666 2691 
8 1114 1135.775 1701 1679.225 2815 
9 1001 995.785 1669 1674.215 2670 
10 898 897.802 1755 1755.198 2653 
 
 
Classification Table
a
 
 
Observed 
Predicted 
 
EWL_referral Percentage 
Correct 
 
Non-provider Provider 
Step 1 EWL_referral Non-provider 7344 6224 54.1 
Provider 4420 8638 66.2 
Overall Percentage   60.0 
a. The cut value is .500 
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